Microbe 2016 Disclosures Listed by Session

Microbe 2016 Disclosures

Listed by Session

Session Title Disclosures

Novel Insights Regarding the Microbiome and Pregnancy (Organized in

Cooperation with the Infectious Diseases Society of Obstetrics and

Gynecology (IDSOG)) K. Aagaard, None.

The Science of Learning L. R. Aaronson, None.

Clinical Microbiology Board Review Course A. Abbott, None.

RNA Modulation and Cellular Signals in Antimicrobial Resistance N. Abdali, None. H.I. Zgurskaya, None.

Parasitology and Anti-parasitic Agents A. Abebe, None. H. Asrat, None. G. Ayana, None.

Emerging Infections in HSCT: Limited Evidence (Organized in

Cooperation with the European Society of Clinical Microbiology and

Infectious Diseases) A. Abudayyeh, None.

Clostridium difficile Epidemiology and Control

T. Miller-Roll, None. W. Na'amnih, None. D. Cohen, None. Y. Carmeli,

None. A. Adler, None.

Epidemiology and Control of Nosocomial MDRO A. Adler, None. R. Glick,None. Y. Carmeli, None.

Decoding Contamination: Addressing Contamination in the Laboratory,

the Hospital and the World E. Afshinnekoo, None.

Clinical Mycology

S. Tripathi, None. D. Levin, None. Q. Feng, None. X. Li, None. M. Jacob,

None. P. Donover, None. M. Reichman, None. A. Clark, None. A. Agarwal,

None.

Primer on Transplantation J. M. Aguado, None.

The Resistance Network: Interplay between Environmental, Community

and Nosocomial Superbugs (Joint ASM-FEMS Symposium) M. Aires-de-Sousa, None.

Antimicrobial Stewardship II R.L. Akins, Investigator; Merck, Theravance Biopharma. M.D. Smith, None.



Infectious Diseases) M. Akova, None.

Encephalitis: What Is New? (Supported Jointly with the Société de

Pathologie Infectieuse de Langue Française (SPILF)) A. Aksamit, None.

Making an Impact: Utilization and Outcomes in the Microbiology Lab K. Alby, None.

Making an Impact: Utilization and Outcomes in the Microbiology Lab K. Alby, None.

Novel Strategies to Help Antibiotics to Play their Role S. Ali, None. R.K. Poole, None.

Next-Generation Sequencing Applied to Clinical Practice and Pathogen

Discovery M. W. Allard, None.

Prevention and Treatment of Infection in the lmmunocompromised Child

& Adolescent U. D. Allen, None.

Foundations to Frontiers: The Molecular Revolution S. Altschul, None.

More Trouble from Ticks in 2016 G. Alvarez-Hernandez, None.

Antimicrobial Breakpoints: Time for a Single CAST?

P. G. Ambrose, Consultant: Arsanis, Contrafect, Merck, Kalidex, Meiji, PTC,

Roche, Spero, Theravance, Tetraphase, VenatoRx, Zavante, Institute for

Clinical Pharmacodynamics, Cempra, Tetraphase, Spero, Paratek, Venato,

UFL, Debiopharm, Wockhardt, Contrafect, Medicines Co., Merck, GSK, 3V

Biosciences, Arsanis, Nabriva. Investigator. USCAST, Zavante Therapeutics.


Listed by Session

Innovations and Challenges in Pharmacokinetics/Pharmacodynamics

(PK/PD)

P. G. Ambrose, Consultant: Arsanis, Contrafect, Merck, Kalidex, Meiji, PTC,

Roche, Spero, Theravance, Tetraphase, VenatoRx, Zavante, Institute for

Clinical Pharmacodynamics, Cempra, Tetraphase, Spero, Paratek, Venato,

UFL, Debiopharm, Wockhardt, Contrafect, Medicines Co., Merck, GSK, 3V

Biosciences, Arsanis, Nabriva. Investigator. USCAST, Zavante Therapeutics. J.

McCauley: Employee; ICPD. C.M. Rubino: Employee; ICPD. K. Shareholder

(excluding diversitied mutual funds). S.M. Bhavnani: Employee; ICPD.

Shareholder (excluding diversitied mutual funds); ICPD.

Novel Strategies to Help Antibiotics to Play their Role R. Amin, None.

Front-end Automation in the Clinical Microbiology Laboratory N. Anderson, None. A. McMullen, None. R. Jennemann, None.

Interplay between Antimicrobial Resistance and Bacterial Persistence D. I. Andersson, None.

Measurement and Modeling of Drugs in Tissues (Organized in

Cooperation with International Society of Anti-Infective Pharmacology

(ISAP))

D. R. Andes: Consultant: Astellas, Actelion, Roche, Theravance, Zavante,

Scynexis, Melinta.

Antimicrobial Resistance Control: A One-Health Approach

A. Andrémont: Da Volterra, Consultant, Scientific Advisor (Review Panel or

Advisory Committee).

Carbapenemases D. Andreotti, None. A. Felici, None. M. Negri, None. C. Napolitano, None.

Surveillance for the 21st Century A. Anyamba, None.

Antimicrobial Resistance among Gram-Positive Bacterial Pathogens:

Continuous and Emerging Challenges, Mechanisms and Epidemiology

C. A. Arias, Theravance, Bayer, Merck, Novartis, Pfizer. Consultant.

Theravance, Merck, Actavis. Grant Investigator. Pfizer, Theravance, The

Medecins Company, Actavis, Bayer, Novartis. Speaker's Bureau.

Crossing the Diagnostic Divide: The Ongoing Evolution of the Revolution

in Clinical and Public Health Microbiology G. Armstrong, None.

Antimicrobial Research Award Lecture: Quinolone and Multidrug

Resistance - A Formidable Foe D. M. Aronoff, Summit Pharmaceuticals. Consultant.

Maurice Hilleman Award Lecture: Towards a Universal Influenza Virus

Vaccine D. M. Aronoff, Summit Pharmaceuticals. Consultant.

ICAAC Lecture: Clean Hands Save Lives: Worldwide Perspectives D. M. Aronoff, Summit Pharmaceuticals. Consultant.

Treatment of HIV Infection

J. R. Arribas, Consultant. Janssen Cilag Consultant. Abbvie Consultant. BMS

Consultant. Gilead. Consultant. MSD. Consultant. Viiv, Grant Investigator.

Janssen Cilag, Grant Investigator. Abbvie, Grant Investigator. BMS, Grant

Investigator. Gilead, Grant Investigator. MSD, Grant Investigator.

Microbiology Research Funding Opportunities R. M. Atlas, None.

We Are Not Alone: Emerging Issues of the Human Mycobiome

(Organized in Cooperation with the lmmunocompromised Host Society

[ICHS]) T. Auchtung, None.

Establishing and Working in a Start-up Environment A. August, None.

New Frontiers in HIV Cure B. Autran, Grant from Janssen, Grant Investigator.

Infectious Diseases Treatment Guidelines and Beyond: Where Do We

Stand in 2016? P. Auwaerter, medical-legal expert testimony.

Lyme Disease 2016 Update

P. Auwaerter, medical-legal

expert testimony

Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance

in Gram-positive Bacteria

A.N.G. Dabul, None. J.S. Avaca-Crusca, None. D.V. Tyne, None. M.S. Gilmore,

None. I.L.B.C. Camargo, None.

Infectious Disease Quiz R. K. Avery, Shire, Merck, Chimerix, Astellas. Investigator.

Challenges of Infections in Lung Transplantation R. K. Avery, Shire, Merck, Chimerix, Astellas. Investigator.

Emerging Technologies and Biomarkers for Fungal Diagnostics E. N. Babady, None.

On Your Bench, Get Set, Go! Practical Updates for the Clinical

Microbiologist E. N. Babady, None.


Listed by Session

RNA Modulation and Cellular Signals in Antimicrobial Resistance

A. Babosan, None. F. Lebreton, None. C. de Champs, None. G. Pier, None. D.

Skurnik, None. T. Guillard, None.

Microbiology Career Choices: What's Available and How to Succeed N. Baker, None.

Error Rates in Clinical Microbiology Laboratories: Where Do We stand?

J. Balada-Llasat, Biomerieux, Scientific Advisor (Review Panel or Advisory

Committee).

Emerging Technologies and Biomarkers for Fungal Diagnostics N. Banaei, None.

Optimal Use of Rapid Diagnostics in the Clinical Microbiology Laboratory

for Quality Improvement and Clinical Care R. Banerjee, None.

Pixels, Paints, and Pop Culture: Unique Perspectives on Science

Communication M. Banks, None.

At the Intersection of Art and Microbiology M. Banks, None.

Practical Advice for Lab Management: CPT Codes, Compliance,

Reimbursement, and LOINC Codes P. Banning, None.

Aiming at Non-Conventional Approaches to TB Therapies (Supported

Jointly by the Bill & Melinda Gates Foundation) A. K. Barczak, None.

Practical Considerations and Novel Applications of MALDI-TOF MS in the

Clinical Laboratory A. P. Barker, None.

Case Management of Tropical Infectious Diseases and Travel Medicine

(Organized in Cooperation with the American Society of Tropical

Medicine and Hygiene (ASTMH))

E. D. Barnett, PaxVax, Investigator. PaxVax, Scientific Advisor (Review Panel

or Advisory Committee).

New Frontiers in HIV Cure D. Barouch, None.

Forty Years after the Double Bind H. A. Barton, None.


Reimbursement, and LOINC Codes V. S. Baselski, None.

Late Breaking Clinical Microbiology Updates from Laboratory Practices

and Professional Affairs Committee V. S. Baselski, None.


S.A. Becka, None. J.A. Gatta, None. E.T. Zeiser, None. J.J. LiPuma: Grant

Investigator; AstraZeneca, Actavis. K.M. Papp-Wallace: Grant Investigator;

AstraZeneca, Actavis, Merck, Wockhardt.

Foundations to Frontiers: The Molecular Revolution J. Beckwith, None.

Staphylococcus aureus Infection Treatments: New Compounds, New

Strategies

K. Begins: Employee; Green Mountain Antibodies. A. Maddur, None. W.

Church: Employee; Green Mountain Antibodies. P. Panizzi: None. P. Bock:

None.

Engaging and Inclusive Teaching in the Microbial Sciences G. S. Begley, None.



Gynecology (IDSOG)) R. Beigi, None.

Lyme Disease 2016 Update J. T. Belisle, None.

Hand Hygiene and Environmental Issues in the Healthcare Setting

F. Bellissimo-Rodrigues: None. H. Soule: None. D. Pires: None. A. Gayet-

Ageron: None. D. Pittet: None.

Clinical Virology L.A. Beltz: None.

Controversies in Antimicrobial Stewardship

B. Beovic, MSD, unrestricted grant to University for my research. Grant

Investigator. Rempex, country principal investigator in a multicentre study.

Investigator. Astellas, Astra Zeneca, Pfizer, MSD, Sandoz - member of local

advisory committees, Scientific Advisor (Review Panel or Advisory

Committee).

Antimicrobial Stewardship Success Stories

B. Beovic, MSD, unrestricted grant to University for my research. Grant

Investigator. Rempex, country principal investigator in a multicentre study.

Investigator. Astellas, Astra Zeneca, Pfizer, MSD, Sandoz - member of local

advisory committees, Scientific Advisor (Review Panel or Advisory

Committee).

Antimicrobial Stewardship I

A. Saje: None. O. Dyar: None. A. Sustar: None. U. Mrsic: None. C. Pulcini:

None. B. Beović:None.

Protecting the Food Supply: From Humble Beginnings to Next Generation

PulseNet J. Besser, None.


Listed by Session

New Beta-lactamase and Carbapenemase Inhibitors

S.S. Takalkar: Employee; Wockhardt Research Center. Shareholder

(excluding diversitied mutual funds); S Wockhardt Ltd. K.V. Umarkar:

Employee; Wockhardt Research Center. J.S. Satav: Employee; Wockhardt

Research Center. A.P. Udaykar: Employee; Wockhardt Research Center. A.M.

Kulkarni: Employee; Wockhardt Research Center. S.S. Bhagwat: Employee;

Wockhardt Research Center. Shareholder (excluding diversitied mutual

funds); Wockhardt Ltd.,. M.V. Patel: Employee; Wockhardt Research Center.

Shareholder (excluding diversitied mutual funds); Wockhardt Ltd.

When the Standard PK/PD Model Does not Apply

S. M. Bhavnani, Institute for Clinical Pharmacodynamics, Employee. USCAST,

Member. Cempra, Melinta, Achaogen, Research Contractor.


(PK/PD)

S.M. Bhavnani: Research Relationship; Cellceutix Corp. J.P. Hammel: Research

Relationship; Cellceutix Corp. A. Forrest:Research Relationship; Cellceutix

Corp.S.A. VanWart: Research Relationship; Cellceutix Corp. P. Sager:

Consultant; Cellceutix Corp. K.J. Tack: Consultant; Cellceutix Corp. R.W.

Scott: Consultant; Cellceutix Corp. D.M. Jorgensen: Employee; Cellceutix

Corp. Shareholder (excluding diversitied mutual funds); Cellceutix Corp. P.G.

Ambrose: Research Relationship; Cellceutix Corp.

Challenges of Infections in Lung Transplantation S. Bhorade, None.

Effective and High Impact Scientific Writing W. Bigford, BioScience Writers. Employee.


Jointly by the Bill & Melinda Gates Foundation)

W. R. Bishai, AVISA: Scientific Advisor (Review Panel or Advisory Committee).

Paratek: Scientific Advisor (Review Panel or Advisory Committee). Scanogen:

Scientific Advisor (Review Panel or Advisory Committee).

Next-Generation Antimicrobial Discovery, Development, and

Susceptibility Testing A. Blazier, None.

Interplay between Antimicrobial Resistance and Bacterial Persistence J. Blázquez, None.

Primer on Transplantation

E. Blumberg, Site PI for clinical trials: Actelion, Ansun, Achaogen, Chimerix,

Roche, Rempex. Grant Investigator. DSMB for Pfizer, BMS, and Glaxo Smith

Kline; speaker at meeting that was sponsored by Astellas

Literature Review

E. Blumberg, Site PI for clinical trials: Actelion, Ansun, Achaogen, Chimerix,

Roche, Rempex. Grant Investigator. DSMB for Pfizer, BMS, and Glaxo Smith

Kline; speaker at meeting that was sponsored by Astellas


Stand in 2016? R. A. Bonomo, None.

Literature Review R. A. Bonomo, None.

Top 10 Beta-lactamase Papers for 2015 R. A. Bonomo, None.

New Beta-lactamase and Carbapenemase Inhibitors R. A. Bonomo, None.


M. Nukaga: Grant Investigator; AstraZeneca, Actavis. S.T. Lefurgy: None.

M.D. Barnes: None. K.M. Papp-Wallace: Grant Investigator;Actavis,

AstraZeneca, Merck, Wockhardt. R.A. Bonomo: Grant Investigator; Actavis,

AstraZeneca, Merck, Wockhardt, GSK.

Diagnostic and Therapeutic Challenges in MDR and XDR Gram-Negatives:

A Cases Based Discussion R. A. Bonomo, None.

Using Poll Everywhere to Engage your ID and Micro Learners B. Boslett, None.

Front-end Automation in the Clinical Microbiology Laboratory R. Botrugno: None. S. Castriciano: None.

Interplay between Antimicrobial Resistance and Bacterial Persistence

G. Bou, Novartis: Collaborator. Pfizer: Grant Investigator. Pfizer, MSD,

Astellas. Scientific Advisor (Review Panel or Advisory Committee).


Listed by Session


G. Bou, Pfizer: Consultant. Pfizer, Roche: Grant Investigator. Pfizer, MSD,

Astellas: Scientific Advisor (Review Panel or Advisory Committee).

Forty Years after the Double Bind D. Boucaud, None.


Stand in 2016?

H. W. Boucher, Achtellion: Consultant. Merck: Consultant.Elsevier:

Consultant. Legal Expert Witness: Consultant.

2016 Cutting Edge Prevention, Diagnosis, and Treatment of Meningitis in

Africa (Organized in Cooperation with the American Society of Tropical


D. R. Boulware, NIH, PI on "Adjunctive Sertraline for the Treatment Of

Cryptococcal Meningitis (ASTRO-CM) trial, Research Relationship.

Clinical Virology B. Bowland: None. T. Van: None. M. Lustestica: None. J. Dien Bard: None.


Strategies

G. Brackman: None. A. Vermote: None. K. Breyne: None. E. Meyer: None. S.

Van Calenbergh:None. T. Coenye: None.

The Science of Learning L. Brancaccio-Taras, None.


Clinical Laboratory J. A. Branda, bioMerieux. Grant Investigator.

Antimicrobial Susceptibility Testing - Where Are We Going? (Organized in

Cooperation with the Society of Infectious Diseases Pharmacists [SIDP]) W. B. Brasso, BD Diagnostic Systems, Employee.

The Microbes Are Winning: A Workshop on Antibiotic Resistance,

Detection, Distribution (PK/PD), and Molecular Epidemiology in

Significant Bacterial Pathogens

S. M. Brecher, Bacterioscan, Cempra, Scientific Advisor (Review Panel or

Advisory Committee). Merck, Speaker's Bureau.

What?s New with Varicella J. Breuer, None.

Epidemiology and Control of Nosocomial MDRO N.S. Britt: None. E.M. Potter: None. N. Patel: None. M.E. Steed: None.

Clostridium difficile Epidemiology and Control G. Broukhanski: None. A. Wang: None.

Bacterial Communication S. Brown, None.

Fresh Approaches to Antibiotic Drug Discovery: Breaking from

Convention

E. D. Brown, Apilli Pharmaceuticals Board Member. PureTech Health

Consultant.

Antiretrovirals for Prevention and Treatment

K. Brown: Employee; Janssen Scientific Affairs. B. Patterson: Employee;

Janssen Scientific Affairs. C. Liu: Employee; Janssen Research & Development.

M. Patel: Employee; Janssen Scientific Affairs. R.E. Nettles: Employee; Janssen

Scientific Affairs. L. Stewart: Employee; Janssen Scientific Affairs.J.

Szwarcberg: Employee; Gilead Sciences.

Developing the Next Gen Scientist: The Role of Course Based Research in

the Undergraduate Curriculum S. Brownell, None.


Clinical Laboratory

B. Buchan, GenMark, Consultant. Meridian, GenMark, Accelerate, BD, Quidel,

Nanosphere, Research Contractor.

Making an Impact: Utilization and Outcomes in the Microbiology Lab

B. Buchan, GenMark, Consultant. Meridian, GenMark, Accelerate, BD, Quidel,

Nanosphere, Research Contractor.


A.E. Budding: Board Member; IS-Diagnostics. Shareholder (excluding

diversitied mutual funds); IS-Diagnostics. M. van der Bijl: None. C.M.J.E.

Vandenbroucke-Grauls: None. P.H.M. Savelkoul: Board Member; IS-

Diagnostics. Shareholder (excluding diversitied mutual funds); IS-Diagnostics.


C.C. Bulik: Consultant; ICPD Tech. Employee; ICPD. J.C. Bader: Consultant;

ICPD Tech. Employee; ICPD. S.M. Bhavnani: Employee; ICPD. Member; ICPD

Tech. Shareholder (excluding diversitied mutual funds); ICPD. D.R. George:

Consultant; ICPD Tech. Employee; ICPD. C.M. Rubino: Employee; ICPD.

Member; ICPD Tech. Shareholder (excluding diversitied mutual funds); ICPD.

P.G. Ambrose: Employee; ICPD. Member; ICPD Tech. Shareholder (excluding

diversitied mutual funds); ICPD. K.L. Sweeney: Consultant; ICPD Tech.

Employee; ICPD.


Listed by Session


(PK/PD)

J.B. Bulitta: Grant Investigator; Pfizer, Cubist, Trius, Cempra, CSL. T. Velkov:

Grant Investigator; The Medicines Company. K. Rogers: None. J. Shan: None.

A. Oliver: Grant Investigator; Cubist, Wockhardt. R.L. Nation: Grant

Investigator; The Medicines Company. J.D. Boyce: None. B.T. Tsuji:. Grant

Investigator; Pfizer, Cubist, Cempra, GSK. C.B. Landersdorfer:Grant

Investigator; Pfizer, Cubist, Trius, CSL.

Antimicrobial Toxicodynamics (Organized in Cooperation with the

International Society of Anti-Infective Pharmacology [ISAP]) J. B. Bulitta, Pfizer, Cubist, Cempra, Trius, CSL, Grant Investigator.

Front-end Automation in the Clinical Microbiology Laboratory E. Burd, bioMerieux Scientific Advisor (Review Panel or Advisory Committee).


Susceptibility Testing E. Burd, bioMerieux Scientific Advisor (Review Panel or Advisory Committee).

Ethics in Laboratory Medicine

C. Burnham, Monsanto Consultant. Thermofisher Consultant. Cepheid Grant

Investigator. bioMerieux Grant Investigator. Accelerate Diagnostics Grant

Investigator.


Susceptibility Testing

C. Burnham, Monsanto Consultant. Thermofisher Consultant. Cepheid Grant

Investigator. bioMerieux Grant Investigator. Accelerate Diagnostics Grant

Investigator.

Top 10 Beta-lactamase Papers for 2015

K. Bush, Achaogen Consultant. Naeja Consultant. Achaogen Research

Contractor. Actavis Research Contractor. Tetraphase Research Contractor.

Achaogen Scientific Advisor (Review Panel or Advisory Committee). Allecra

Scientific Advisor (Review Panel or Advisory Committee). Entasis Scientific

Advisor (Review Panel or Advisory Committee). Gladius Scientific Advisor

(Review Panel or Advisory Committee). Melinta Scientific Advisor (Review

Panel or Advisory Committee). Roche Scientific Advisor (Review Panel or

Advisory Committee). Tetraphase Scientific Advisor (Review Panel or Advisory

Committee). WarpDrive Scientific Advisor (Review Panel or Advisory

Committee). Fedora Shareholder (excluding diversitied mutual funds).

Johnson & Johnson Shareholder (excluding diversitied mutual funds). Johnson

& Johnson.














& Johnson.


S. Bush: Employee; Gilead Sciences. D. Magnuson: Employee; Gilead

Sciences. M. Rawlings: Employee; Gilead Sciences. T. Hawkins: Employee;

Gilead Sciences.S. McCallister: Employee; Gilead Sciences.R. Mera

Giler:Employee; Gilead Sciences.


Listed by Session













& Johnson.


& Adolescent K. M. Butler, None.

New insights on Emerging Resistance Mechanisms in Gram-negatives

J.M. Buyck: None. P. Saint Auguste: None. C. Schleberger: None. D. Bumann:

None.



V. Cafiso: None. S. Stracquadanio: None. G. Pigola: None. A. Ferro: None. S.

Stefani: None.


A. Caliendo, Hologic Research Relationship. T2 Biosystems Research

Relationship. Roche Molecular Scientific Advisor (Review Panel or Advisory

Committee). BioFire Technologies/bioMerieux Scientific Advisor (Review

Panel or Advisory Committee). Quidel Scientific Advisor (Review Panel or

Advisory Committee). Cepheid Scientific Advisor (Review Panel or Advisory

Committee). IBIS Biosciences Scientific Advisor (Review Panel or Advisory

Committee). Nanosphere Scientific Advisor (Review Panel or Advisory

Committee). IncellDX Scientific Advisor (Review Panel or Advisory

Committee).


and Professional Affairs Committee

A. Caliendo, Hologic Research Relationship. T2 Biosystems Research

Relationship. Roche Molecular Scientific Advisor (Review Panel or Advisory

Committee). BioFire Technologies/bioMerieux Scientific Advisor (Review

Panel or Advisory Committee). Quidel Scientific Advisor (Review Panel or

Advisory Committee). Cepheid Scientific Advisor (Review Panel or Advisory

Committee). IBIS Biosciences Scientific Advisor (Review Panel or Advisory


Committee). IncellDX Scientific Advisor (Review Panel or Advisory

Committee).

New Insights Into Enterococcal Pathogenesis and Antibiotic Resistance in

the Genomic Era I. L. Camargo, None.

New Frontiers in HIV Cure P. Cannon, Sangamo BioSciences, Inc., Research Relationship.

Resistance Surveillance and Public Health R. Cantón, None.

Making an Impact: Utilization and Outcomes in the Microbiology Lab G. A. Capraro, None.

Interplay between Antimicrobial Resistance and Bacterial Persistence A. Carattoli, None.

New insights on Emerging Resistance Mechanisms in Gram-negatives A. Carattoli, None.

Carbapenemases A. Carattoli, None.

Microbial Speciation and Antimicrobial Resistance Evolution in the

Genomic Era A. Carattoli, None.

RNA Modulation and Cellular Signals in Antimicrobial Resistance A. Carattoli, None.

Implementation of the Best Infection Control Practices: Worldwide

Progress Reports D. M. Cardo, None.


P. C. Carling, Ecolab, Steris, AORN . Consultant. Patents

licensed to ecolab. .


Listed by Session

NGS for Microbial Genomic Surveillance and More - One Technology Fits

All J. Carriço, None.

Surveillance for the 21st Century M. Carroll, Quidel Scientific Consultant. McGraw-Hill, Inc.

Who Paves the Way for Fungi: Genes or Doctors? (Organized in

Cooperation with the lmmunocompromised Host Society (ICHS)) A. Carvalho, Institut Mérieux Research Contractor.

Beyond the Bench: The Intangibles of Being a Microbiologist A. Casadevall, None.

Let's Talk about Sex! STIs and the Challenges of Diagnosis and Treatment

J. Cassell, I am Editor in Chief of the BMJ journal "Sexually Transmitted

Infections".

Parasitology and Anti-parasitic Agents M. Cassera, None.


M. Castanheira: Research Contractor; This study and abstract presentation

were funded by a research grant from Achaogen, Inc. A.P. Davis: Research

Contractor; This study and abstract presentation were funded by a research

grant from Achaogen, Inc.T.B. Doyle: Research Contractor; This study and

abstract presentation were funded by a research grant from Achaogen, Inc.

R.E. Mendes: Research Contractor; This study and abstract presentation were

funded by a research grant from Achaogen, Inc. R.N. Jones: Research


grant from Achaogen, Inc.

Front-end Automation in the Clinical Microbiology Laboratory S. Castriciano: None. J. Steenbergern: None.


in Gram-positive Bacteria V. Cattoir, None.


Continuous and Emerging Challenges, Mechanisms and Epidemiology V. Cattoir, None.

Error Rates in Clinical Microbiology Laboratories: Where Do We stand? R. Cavagnolo, None.


Stand in 2016?

H. F. Chambers, Genentech Grant Investigator. Medicines Company Grant

Investigator. Genentech Scientific Advisor (Review Panel or Advisory

Committee). Allergan Scientific Advisor (Review Panel or Advisory

Committee). Theravance Scientific Advisor (Review Panel or Advisory

Committee). MerckShareholder (excluding diversitied mutual funds).

lmmunoreconstitution (IRIS): How to Diagnose? How to Differentiate?

How to Treat? (Organized in Cooperation with the lmmunocompromised

Host Society (ICHS)) C. Chang, None.

Decreased Antibiotic Efficacy in Renal Impairment: Are We Getting the

Dose Wrong? (Organized in Cooperation with the Society of Infectious

Diseases Pharmacists [SIDP]) S. Chen, None.



Medicine and Hygiene (ASTMH)) L. Chen, Shoreland, InConsultant.

Novel Strategies to Help Antibiotics to Play their Role

K. Chiem: None. B.A. Fuentes: None. D.L. Lin: None. T. Tran: None. A.

Jackson: None. M.S. Ramirez: None. M.E. Tolmasky: None.

Using Poll Everywhere to Engage your ID and Micro Learners P. V. Chin-Hong, None.

Epidemiology and Control of MRSA

O. Cho: None. K. Park: None. E. Baek: None. M. Bak: None. O. Jang: None. I.

Bae: None.

New Antifungals

M.H. Chowdhury: None. L.K. Ryan: None. K.B. Freeman: Employee;

Employee of Fox Chase Chemical Diversity Center. R.W. Scott: Employee;

Employee of Fox Chase Chemical Diversity Center. G. Diamond: None.

Cases in Clinical Microbiology D. Church, None.


(PK/PD)

J. Cies: Consultant; Atlantic Diagnostic Laboratories. W. Moore: None. A.

Enache: None. A. Chopra: None.


Listed by Session

Chemistry and Microbiology BFF: Beyond MALDI-TOF MS Technology

J. D. Cirillo, Global BioDiagnostics Corp.. Consultant. Merck Grant

Investigator. Global BioDiagnostics Corp. Scientific Advisor (Review Panel or

Advisory Committee). Global BioDiagnostics Corp. Shareholder (excluding

diversitied mutual funds).

RNA Modulation and Cellular Signals in Antimicrobial Resistance L. Citterio: None. H. Franzyk: None. L. Gram: None.

Primer on Transplantation C. Clancy, None.

Nosocomial Outbreaks

B. Decker: None. L. Chen: None. A. Sonel: None. M. Nguyen: None. B.

Kreiswirth: None. C. Clancy: None.

Clinical Virology R. J. Lovich, None. R. Mody, None. J. Sherewood, None. E. A. Co, None.

Interactive Cases in Pediatric Infectious Diseases (Organized in

Cooperation with the Pediatric Infectious Diseases Society (PIDS)) S. E. Coffin, None.

Tips for Writing Grant Applications E. Cohen, None.

Lights, Camera, Science! Engaging Videos 101 C. Condayan, None.

Microbiology in the World of Social Media C. Condayan, None.

Front-end Automation in the Clinical Microbiology Laboratory L. Conter: None. B. Massetti: None. R. Paroni: None. S. Castriciano: None.

Difficult Viral Infections in HSCT C. Cordonnier, None.

Getting Hired: Job Search Strategies and Crafting Your CV/Resume C. N. Cornelissen, None.

Effective Interviewing Skills and Job Offer Negotiation C. N. Cornelissen, None.


E. Charpentier: None. C. Garnaud: None. C. Wintenberger: None. J. Rendu:

None. P. Pavese: None. T. Drouet: None. C. Augier: None. P. Malvezzi:

None. A. Thiébaut: None.


Progress Reports L. Correa, None.

Antimicrobial Stewardship Success Stories S. E. Cosgrove, None.

How to Use Behavioral Theories to Design an Effective Antimicrobial

Stewardship Program S. E. Cosgrove, None.


Jointly by the Bill & Melinda Gates Foundation) J. S. Cox, None.



Medicine and Hygiene (ASTMH)) C. M. Coyle, None.


Microbiologist

D. W. Craft, Sanofi-Pasteur Scientific Advisor (Review Panel or Advisory

Committee). BioFire Scientific Advisor (Review Panel or Advisory Committee).

Nontuberculous Mycobacterium (NTM) Infections Associated with

Cardiopulmonary Bypass Surgery: Investigation of an Outbreak

D. W. Craft, Sanofi-Pasteur Scientific Advisor (Review Panel or Advisory

Committee). BioFire Scientific Advisor (Review Panel or Advisory Committee).

Clinical Applications of Next Generation Sequencing

K. Crandall, Aperiomics Inc.. Board Member. Aperiomics Inc. Research

Relationship. Aperiomics Inc. Shareholder (excluding diversitied mutual

funds).

RNA Modulation and Cellular Signals in Antimicrobial Resistance J.K. Crane: None. B.E. Bunnell: None. K.L. Bair: None. M.D. Sutton: None.


Susceptibility Testing D. W. M. Crook, None.


in Clinical and Public Health Microbiology A. Croxatto, None.


in Gram-positive Bacteria I. Takeuchi: None. T.D. Curtis: None. L. Gram: None. G. Knudsen: None.

New Antifungals M.T. Cushion: None. A. Ashbaugh: None. K. Lynch: None. M.J. Linke: None.

Novel Vaccines: From Basic Research Through Clinical Development

R. Dagan, Pfizer, MSD, Genocea, Memed Consultant. Pfizer Grant

Investigator. Pfizer Investigator. Pfizer Research Contractor. Pfizer Research

Relationship. Pfizer< Scientific Advisor (Review Panel or Advisory

Committee). Pfizer, GSK Speaker's Bureau.


Listed by Session

Hot Topics in Vaccines (Organized in Cooperation with the Pediatric

Infectious Diseases Society (PIDS))





How to Write an Abstract





Preventing Pediatric Infection (Supported jointly by the Bill & Melinda

Gates Foundation) (Organized in Cooperation with the Pediatric







A Cases Based Discussion G. L. Daikos, ACHAOGEN Research Contractor. REMPEX Research Contractor.


Strategies A. Dalecki: None. F. Wolschendorf: None.


L. Danziger-Isakov, Ansun Biopharma, Roche, Chimerix, Research

Contractor.

Infectious Disease Quiz


Contractor.

Challenges of Infections in Lung Transplantation


Contractor.


K. Davies: Research Relationship; Sanofi Pasteur. G. Davis: Research

Relationship; Sanofi Pasteur. F. Barbut: Research Relationship; Sanofi Pasteur.

C. Eckert: Research Relationship; Sanofi Pasteur. N. Petrosillo: Research

Relationship; Sanofi Pasteur. R. Pisapia: Research Relationship; Sanofi

Pasteur. E. Reigadas-Ramirez: Research Relationship; Sanofi Pasteur. E.

Bouza: Research Relationship; Sanofi Pasteur. F. Berger: Research

Relationship; Sanofi Pasteur. M. Herrmann: Research Relationship; Sanofi

Pasteur. M. Wilcox: Research Contractor; Sanofi Pasteur.



M. Davlieva: None. A. Tovar-Yanez: None. K. DeBruler: None. P. Leonard:

None. M. Zianni: None. C. Arias: None. S. Yousif: None.

Epidemiological Methods to Evaluate the Added Burden of MDRO

Infection

M. de Kraker, Innovative Medicines Initiative Joint Undertaking, EU 7th

framework programme, EFPIA partners in kind contribution, Investigator.

Emerging Technologies and Biomarkers for Fungal Diagnostics C. Decristoforo, None.

Infectious Disease Quiz K. Dee, None.


Discovery J. Dekker, None.

Novel Vaccines: From Basic Research Through Clinical Development B. DeLaine: None. C. Grassel: None. T. Wu: None. E.M. Barry: None.

Chemistry and Microbiology BFF: Beyond MALDI-TOF MS Technology M. DeMarco, None.

Escherichia coli : A Friend or an Enemy? E. Denamur, None.

Basics of Pharmacokinetics and Pharmacodynamics (PK/PD) of Anti-

infective Agents (Organized in Cooperation with International Society of

Anti-Infective Pharmacology [ISAP]) H. Derendorf, None.

PK/PD Questions I Was Too Afraid to Ask (Organized in Cooperation with

the International Society of Anti-Infective Pharmacology [ISAP]) H. Derendorf, None.

Mycobacteriology 2016: Supporting the Care of Patients with

Mycobacterial Infections in an Increasingly Molecular Laboratory

Environment E. Desmond, None.


D. Deveson Lucas: None. D. Powell: None. D. Bulach: None. A. Wright:

None. J. Li: None. M. Harper: None. J.D. Boyce: None.

Engaging and Inclusive Teaching in the Microbial Sciences B. Dewsbury, None.

Broadly Neutralizing Antibodies M. Diamond, None.


Listed by Session

Clinical Virology

P. Colson: None. C. Tamalet: None. C. Dhiver: None. I. Ravaux: None. A.

Stein: None. R. Didier: None.

Future Microbiology-Predicting the Field in 2026 J. Dien Bard, BioFire, Nanosphere Research Relationship.

Clinical Microbiology Board Review Course J. Dien Bard, None.

Clinical Update on Hepatitis R. Dillingham, None.

Zika Virus: An Emerging Threat G. Dimopoulos, None.

Clinical Virology

D.L. Dinwiddie: None. K. Schwalm: None. W.N. Dehority: None. S.A.

Young:None.

Antimicrobial Stewardship in Hospitals

E. Dodds Ashley, Hospital Association of New York, Consultant. New York

Council of Health System Pharmacists, Consultant.

Pediatric Microbiology for Clinicians and Laboratorians

C. Doern, ThermoFisher Scientific Advisor (Review Panel or Advisory

Committee). Cepheid Scientific Advisor (Review Panel or Advisory


Committee). Genmark Scientific Advisor (Review Panel or Advisory

Committee). BD. Scientific Advisor (Review Panel or Advisory Committee).













QuizBusters - So You Think You Know Clinical Microbiology?






Resistance Surveillance and Public Health

Y. Doi, The Medicines Company Grant Investigator. Meiji Scientific Advisor

(Review Panel or Advisory Committee). Tetraphase Scientific Advisor (Review

Panel or Advisory Committee).


A Cases Based Discussion

Y. Doi, The Medicines Company Grant Investigator. Meiji Scientific Advisor

(Review Panel or Advisory Committee). Tetraphase Scientific Advisor (Review


Effective Interviewing Skills and Job Offer Negotiation B. Dolan, None.



Gynecology (IDSOG)) M. Dominguez-Bello, None.

Control of C. difficile Infection

C. Donskey, 3M Board Member. Seres Health Board Member. EcoLab

Research Relationship. GOJO Research Relationship. Merck Research

Relationship. 3M Research Relationship. Synthetic Biologics Research

Relationship. CepheidResearch Relationship.

Infectious Disease Quiz R. Doster, None.

Friends, Foes, and Foils: Defining Microbial Interactions featuring the

ASM Lecturer and Distinguished Lecturers

J. A. Doudna, Caribou Biosciences Scientific Advisor (Review Panel or Advisory

Committee). Intellia Therapeutics Scientific Advisor (Review Panel or Advisory

Committee). Caribou Biosciences - Co-founder. Editas Medicine - Co-founder.

Intellia Therapeutics - Co-founder.

Hot Topics in Antimicrobial Susceptibility Testing C. Dragoni: None. M. Ianosi-Irimie: None. N. Matluk: None.


Listed by Session


R. H. Drew, CustomID, Collaborator. American Society of Microbiology,

Campbell University, Speaker's Bureau.



(ISAP))

G. L. Drusano, Roche, Consultant. Polyphor, Consultant. Roche, Grant

Investigator. Achaogen, Grant Investigator. NIAID, Grant Investigator. Zavante

Pharmaceuticals, Scientific Advisor (Review Panel or Advisory Committee).

Roche, Scientific Advisor (Review Panel or Advisory Committee).

When the Standard PK/PD Model Does not Apply

G. L. Drusano, Roche, Consultant. Polyphor, Consultant. Roche, Grant

Investigator. Achaogen, Grant Investigator. NIAID, Grant Investigator. Zavante

Pharmaceuticals, Scientific Advisor (Review Panel or Advisory Committee).

Roche, Scientific Advisor (Review Panel or Advisory Committee).

PK/PD Optimization against Carbapenamase Producing Bacteria

M. Dudley, The Medicines Company, Employee. The Medicines Company,

Shareholder (excluding diversitied mutual funds).

Antimicrobial Discovery Approaches E. M. Duffy, Melinta Therapeutics, Inc., Employee.

Clostridium difficile Epidemiology and Control R. A. Duncan, None.


J. Dunn, Nanosphere, Inc. Scientific Advisor (Review Panel or Advisory

Committee).

Cases in Clinical Microbiology

J. Dunn, Nanosphere, Inc. Scientific Advisor (Review Panel or Advisory

Committee).


G. Durand, biomerieux, Employee. M. Bes None. J. Veyrieras, bioMérieux,

Employee. F. Javerliat, bioMérieux, Employee. F.

Vandenesch, None. A. Tristan, None.

Clinical Update on Hepatitis

G. Dusheiko, Gilead, AbbVie, BMS, Janssen, Merck, Consultant. Gilead,

AbbVie, BMS, Janssen, Merck, Scientific Advisor (Review Panel or Advisory

Committee). Regulus, Shionogi, .

Antimicrobial Stewardship II

O.J. Dyar: None. D. Nathwani: I.C. Gyssens: None. C. Stålsby Lundborg: None.

C. Pulcini: None.


B. Dylla: None. P. Kohner: None. S. Ihde: None. J. Berry: None. K. Monson

Jobe: None. D.J. Hata:None. R. Thompson: None. T. Grys: None. R. Patel:

Grant Investigator; nanoMR, BioFire, Check-Points, Curetis, 3M, Merck,

Actavis, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, Allergan,

The Medicines Company. ; Dr. Patel has a patent Bordetella

pertussis/parapertussis PCR with royalties paid to TIB, a patent

Device/method for sonication with royalties paid to Samsung, and a patent

anti-biofilm substance issu, non-financial support from bioMérieux, Bruker,

Abbott, Nanosphere, Siemens, BD, from Curetis.


the Genomic Era A. Earl, Synlogic, LLC, Consultant. Janssen Pharmaceuticals, Consultant.


H.L. Cox: None. M.M. Richey: None. A.J. Mathers: None. W.M. Novicoff: J.C.

Eby: None.

Literature Review

M. S. Edwards, Pfizer Research Relationship. IDSA Clinical

Practice Guidelines Committee, Scientific Advisor (Review Panel or Advisory

Committee). Gates Foundation Advisory Committee for GBS MCS study,


How to Write an Abstract M. S. Edwards, Pfizer, Research Relationship.



Infectious Diseases Society (PIDS)) M. S. Edwards, Pfizer, Inc. Research Relationship.

GBS Diseases: Global Challenges A. Efstratiou, None.

Aspergillosis following Viral Infections

H. Einsele, Janssen, Board Member. Celgene, Board Member. Amgen, Board

Member. Novartis, Board Member. Janssen, Consultant. Celgene, Consultant.

Amgen, Consultant. Novartis, Consultant.

Beyond the Bench: The Intangibles of Being a Microbiologist K. Elkins, None.

Preparing Your Education and Engagement Research for Publication:

Qualitative Research for Dummies S. Elliot, None.


Listed by Session

The Science of Learning S. Elliott, None.

Surveillance for the 21st Century V. Emery, Qiagen UK.


O. Bernasconi: None. E. Kuenzli: None. J. Pires: None. S. Kasraian: A.

Carattoli: None. C. Hatz: V. Perreten: None. A. Endimiani: None.

New insights into Urinary Tract Infections D. Eris, None.


Strategies

C.W. Euler: None. N. Frank: None. V.A. Fischetti: Research Relationship;

Contrafect Corporation. Scientific Advisor (Review Panel or Advisory

Committee); Contrafect Corporation.

Advances in Study Design S. Evans, None.

Alexander Fleming and the Beginnings of Biofilm Research D. E. Eveleigh, None.

Novel Insights into C. difficile Pathogenesis: Toxins and Beyond R. Fagan, AvidBiotics Corp. Research Relationship.


Qualitative Research for Dummies B. Fahnert, None.

Non-Tuberculous Mycobacteria (Organized in Cooperation with the

International Society for Chem apy for Infection and Cancer) J. O. Falkinham, None.

Tips for Writing Grant Applications M. Feili-Hariri, None.

Genome-wide Association Studies and Comparative Genomics for

Tracking Multi-resistant and Hypervirulent Bacterial Clones A. M. S. Figueiredo, None.


Tracking Multi-resistant and Hypervirulent Bacterial Clones A. M. S. Figueiredo, None.


Stand in 2016?

T. M. File, Cempra, Consultant. Melinta; Merck; MotifBio; Nabriva; Pfizer;

Tetra-phase, Scientific Advisor (Review Panel or Advisory Committee). Paratek

(member DSMB).



Infectious Diseases Society (PIDS)) A. Finn, None.

Parasitology and Anti-parasitic Agents J.E. Foderaro: None. F. Tran: None. N.J. Westwood: None. G.E. Ward: None.

Clinical Applications of Next Generation Sequencing B. A. Forbes, None.

Advances in Clinical Microbiology from the Horse's Mouth K. M. Frank, None.


Discovery K. M. Frank, None.

The Calm before the Storm: A Practical Guide for Surveillance of

Carbapenem-resistant and Carbapenemase-producing Organisms

(CRO/CPO) K. M. Frank, None.

Foundations to Frontiers: The Molecular Revolution

C. M. Fraser, Becton Dickinson Co., Board Member. University of Maryland

School of Medicine, Employee.

ID Fellows 101: For Fellows Age 18-88 D. N. Fredericks, Metrodora, Consultant.



Infectious Diseases)

A. Freifeld, Merck, Investigator. Merck - member of data adjudication board/

Astellas - member of data safety monitoring board, Scientific Advisor (Review




Infectious Diseases)

A. Freifeld, Merck, Investigator. Merck - member of data adjudication board/

Astellas - member of data safety monitoring board, Scientific Advisor (Review



the International Society of Anti-Infective Pharmacology (ISAP)) L. Friberg, F. Hoffmann-La Roche Ltd, Collaborator.

Epidemiology and Control of Nosocomial MDRO

P. Hogan: None. M. Wallace: None. D.K. Warren: None. C.A. Burnham:

None. S.A. Fritz: None.

Infectious Disease Quiz S. Fritz, None.

Establishing and Working in a Start-up Environment S. Frye, Lasergen, Inc. Employee.


Listed by Session


N. Fursova: None. E. Astashkin: None. A. Lev: None. N. Kartsev: None. E.

Leonova: None. O. Ershova: None. N. Volozhantsev: None. V. Malikov:

None. E. Svetoch: None. I. Dyatlov: None.


C. Fyfe: Employee; C. Fyfe. K. Taquechel: Employee; Kiara Taquechel. Y.

Gao: Employee; Y. Gao. J.A. Sutcliffe: Employee; J. Sutcliffe. T.H. Grossman:

Employee.

Antimicrobial Discovery Approaches

F. Gabbay, Phico Therapeutics Board Member. TranScrip Partners Board

Member. TranScrip & clients Consultant. Phico Therapeutics Employee.

TranScrip Partners, Member. TranScrip & clients Research Contractor. Phico

Therapeutics Shareholder (excluding diversitied mutual funds). TranScrip

Partners Shareholder (excluding diversitied

mutual funds).


and Nosocomial Superbugs (Joint ASM-FEMS Symposium)

A. Gales, AstraZeneca, MSD Board Member. PAHO, Brazilian Health

Surveillance Agency Collaborator. Achaogen ACHN-490-007

Investigator.

Treatment of HIV Infection R. T. Gandhi, Educational grants from Gilead, Roche and EBSCO

Treatment of HIV Infection F. Garcia, None.


Continuous and Emerging Challenges, Mechanisms and Epidemiology S. L. Gardete, None.


All J. L. Gardy, None.


Communication J. L. Gardy, None.

Front-end Automation in the Clinical Microbiology Laboratory

M. Gaskin: None. D. Yamamura: None. J. Korver:

None.

Antimicrobial Stewardship in Hospitals R. Gaynes, None.

Emerging Viral Infections S. Gerber, None.


A. Geretti, Gilead Grant Investigator. BMS Grant Investigator. Janssen

Grant Investigator. ViiV Grant Investigator. Gilead Scientific Advisor

(Review Panel or Advisory Committee). BMS Scientific Advisor (Review

Panel or Advisory Committee). ViiV Scientific Advisor (Review Panel or

Advisory Committee). Pfizer S cientific Advisor (Review Panel or Advisory

Committee). Abbott Molecular Scientific Advisor (Review Panel or Advisory

Committee). Abbott Molecular Speaker's Bureau. Gilead Speaker's Bureau.

ViiV Speaker's Bureau. Pfizer Speaker's Bureau.



(ICHS)) M. A. Ghannoum, None.


the Genomic Era M. S. Gilmore, None.

Antiretroviral for Prevention R. Gilson, None.

Pneumonia Etiology of Infants in Resource Limited Settings: 2016 Update

on Diagnostics, Prevention and Treatment (Supported jointly by Bill &

Melinda Gates Foundation) (Organized in Cooperation with the American

Society of Tropical Medicine and Hygiene) A. Ginsburg, None.



Infectious Diseases) C. Girmenia, None.


All

R. Goering, Cepheid, Merck, Actelion

Research Relationship. bioMérieux

Speaker's Bureau.


R. Goering, Cepheid, Merck, Actelion

Research Relationship. bioMérieux

Speaker's Bureau.


Listed by Session

How to Change the Reporting of Microbiology Results to Improve

Antibiotic Prescribing (Organized in Cooperation with the Society of

Infectious Diseases Pharmacists (SIDP))

D. A. Goff, Allergan OpGen Scientific Advisor (Review Panel or Advisory

Committee). Merck, Astellas, Cepheid Speaker's Bureau.


Genomic Era J. Gogarten, None.

Myths in Infection Control D. Goldmann, None.




S. Goldstone, Merck and Co. on Gardasil Consultant. Merck and Co.

perform Gardasil trials Investigator. Merck and Co, for Gardasil Scientific

Advisor (Review Panel or Advisory Committee). Merck and Co for Gardasil

Speaker's Bureau.

New Antifungals

J.D. Puerta-Arias: None. P.A. Pino: None. J. Arango: None. A.

Gonzalez: None.

Technology Enhanced Learning for the Infectious Diseases and

Microbiology Educator (Supported jointly by IDSA and AMSMIC) R. J. Gordon, None.

Environmental Enteropathy During Infancy: Malnutrition and Growth

Stunting (Supported jointly with the Bill & Melinda Gates Foundation)


Medicine and Hygiene (ASTMH)) J. Gordon, None.


A. Gramatniece: None. M. Saule: None. I. Silamikelis: None. E. Dimina:

None. I. Zahare: None. D. Fridmanis: None. I. Zahare: None. J. Klovins:

None. U. Dumpis: None.

Clinical Virology

J. Capsec: None. D. Brand: None. A. Chaillon: None. F. Cazein: None. S. Levu:

None. A. Moreau: None. J. Pillonel: None. A. Millon: None. S. Brunet:

None. D. Thierry: None. D. Smith: None. F. Lot: None. F. Barin: None. L.

Grammatico-Guillon: None.

Models and Technologies for Studying Pathogenesis A. J. Grant, None.

New insights into Urinary Tract Infections M. Grayson, None.

Infectious Disease Quiz M. Grayson, None.


Progress Reports M. Grayson, None.

Clinical Virology

D.A. Green: None. L. Hitoaliaj: None. S. Campbell: None. D.R. Peaper:

Speaker's Bureau; Nanosphere.

Clinical Virology D. Green, None.


Strategies M. Greenberg: None. D. Kuo: None. G. Yu: None. M. Shoham: None.


Communication S. D. Greenwood, None.

Challenges of Infections in Lung Transplantation A. Gregson, None.

Integration of MALDI-TOF MS in Clinical Laboratories-Two Laboratories'

Experiences

G. Greub, with BD Kiestra on automation and with SUEZ-ONDEO on

metagenomics of tap water, Research Relationship.


Infectious Diseases Society (PIDS)) C. G. Grijalva, Pfizer InConsultant.


A. Gronowski, Church and Dwight Co Inc ., Consultant. Abbott

Laboratories Research Relationship.

Resistance Surveillance and Public Health H. Grundmann, None.

Emerging Technologies and Biomarkers for Fungal Diagnostics T. Grys, None.

Fecal Transplantation for Clostridium difficile Infection

B. Guéry, Astellas Board Member. MSD Scientific Advisor (Review Panel or



Stand in 2016?

K. Gupta, Melinta Therapeutics Consultant. UpToDate, Inc Consultant.

Paratek Pharmaceutical Scientific Advisor (Review Panel or Advisory

Committee). Tetraphase Pharmaceutical Scientific Advisor (Review Panel or


Carbapenemases

M. Litterio: None. D. Cejas: None. G. Gutkind: None. M.A. Radice:

None.

Microbiology in the World of Social Media D. Haeusser, None.


Listed by Session

Carbapenemases

G. Haidar: None. C.J. Clancy: None. L. Chen: None. B. Kreiswirth:

None. M.H. Nguyen: None.


Reimbursement, and LOINC Codes B. L. Haller, None.

Lyme Disease 2016 Update

J. Halperin, Expert witness in medical malpractice cases related to Lyme

disease

Emerging Viral Infections S. Halstead, None.


Genomic Era A. M. Hammerum, None.

Attacking the MDR Puzzle from the Direction: Non-Antibiotic Approaches

to Treating Bacterial Infections

R. E. Hancock, ABT Innovations Board Member. Elanco Animal Health,

Consultant. ABT Innovations, Shareholder (excluding diversitied mutual

funds).

Alexander Fleming and the Beginnings of Biofilm Research M. J. Hanophy, None.


J. Haque: None. N. Ledeboer: None. L. Michaelis: None. M. Graham:

None. P. Hari: None. T. Mackey: None. K. Acker: None. R. Long: None.

J.N. Wainaina: None. S. Revolinski: None. B. Shaw: None. M. Horowitz:

None. S. Munoz-Price:Consultant; Xenex and Clorox. Speaker's Bureau;

Ecolab.

Myths in Infection Control S. J. Harbarth, Novatis Consultant. Bioreieax Research Relationship.


All

D. Harmsen, Co-founder and shareholder of Ridom GmbH (Münster,

Germany) a bioinformatics company


Clinical Microbiology Board Review Course A. Harrington, None.

Advances in Clinical Microbiology from the Horse's Mouth S. Harrington, None.

Error Rates in Clinical Microbiology Laboratories: Where Do We stand? A. Harrington, None.

Front-end Automation in the Clinical Microbiology Laboratory S. Harrington, None.


the Hospital and the World A. Harrington, None.


Cardiopulmonary Bypass Surgery: Investigation of an Outbreak B. Hasse, None.


the Undergraduate Curriculum G. Hatfull, None.

Friends, Foes, and Foils: Defining Microbial Interactions featuring the

ASM Lecturer and Distinguished Lecturers G. Hatfull, None.

Emerging Technologies and Biomarkers for Fungal Diagnostics

R. T. Hayden, Quidel Corporation, Roche Diagnostics Corporation Scientific

Advisor (Review Panel or Advisory Committee).



(CRO/CPO) M. Hayden, None.


G. He: None. X. Li: None. J. Jin: None. D. Lam: None. H. Chen: None.

E. Nou: None.

Establishing and Working in a Start-up Environment M. Healy, None.




C. Healy, Grant recipient Novartis Vaccines-grant ended February 2015,

Research Relationship.

Guess the Resistance Mechanism (Organized in Cooperation with the

Society of Infectious Diseases Pharmacists (SIDP)) E. Heil, Astellas Scientific Advisor (Review Panel or Advisory Committee).


J. Heinrichs, science writer. Spouse/Life Partner, Consultant. Sanofi

Pasteur Employee.

Zika Virus: An Emerging Threat F. X. Heinz, None.


Listed by Session

Hot Topics in Antimicrobial Susceptibility Testing

A. Nguyen: None. A. Heirali: None. M. Workentine: None. R. Somayaji:

None. D. Storey: None. W. Leung: Grant Investigator; Gilead Sciences. B.

Quon: Grant Investigator; Gilead Sciences. H. Rabin: Grant Investigator;

Gilead Sciences. M. Surette: Grant Investigator; Gilead Sciences. M.

Parkins: Grant Investigator; Gilead Sciences.

Clinical Virology Z. H. Helal, None. J. Li, None. M. I. Khan, None.


F.L. Paganelli: None. T. van de Kamer: None. R.J.L. Willems: None. H.L.

Leavis: None. M.J.M. Bonten: None. A.P. Hendrickx: None.

Microbiology Research Funding Opportunities M. Hepburn, None.

Engaging and Inclusive Teaching in the Microbial Sciences J. A. Herzog, None.

The Science of Learning J. A. Herzog, None.

New Antifungals

M.F. Pritchard: Research Relationship; Algipharma AS. A.A. Jack: Research

Relationship; Algipharma AS. L.C. Powell: Research Relationship;

Algipharma AS. H. Sadh: Research Relationship; Algipharma AS. E.

Onsøyen: Employee; Algipharma AS. P.D. Rye: Employee; Algipharma AS.

K.E. Hill: Research Relationship; Algipharma AS. D.W.

Thomas: Research Relationship; Algipharma AS.

AST Update: Clinical and Laboratory Impact

J. Hindler, Accelerate Diagnostics, Inc. Scientific Advisor (Review Panel or

Advisory Committee). bioMerieux Speaker's Bureau.

New Frontiers in HIV Cure Y. Ho, None.

Emerging Viral Infections R. Hodinka, None.

Big Challenges in Pre-clinical Med Student Microbiology Education

(Supported jointly by IDSA and AMSMIC) R. Hodinka, None.


E. Hohmann, Seres Therapeutics Consultant. Suffinova Consultant. Arkin

Holdings Consultant. Back Bay Lifesciences Consultant. Seres Therapeutics

Research Relationship.


Genomic Era K. Holt, None.

Front-end Automation in the Clinical Microbiology Laboratory

M. Jetter: None. M. Marchesi: None. M. Hombach: None. P.M. Keller:

None.


Resistance - A Formidable Foe D. C. Hooper, None.

Update on the Laboratory Diagnosis of Urinary Tract Infections T. M. Hooton, None.

Engaging and Inclusive Teaching in the Microbial Sciences R. Horak, None.

The Science of Learning R. Horak, None.


International Society for Chem apy for Infection and Cancer)

P. Hsueh, Bayer, Astrazenica, Biomerieux, BD, MSD, Sanofi, Abbott,

Consultant.

Fecal Transplantation for Clostridium difficile Infection

P. Hsueh, Bayer, Astrazenica, Biomerieux, BD, MSD, Sanofi, Abbott,

Consultant.

Chemistry and Microbiology BFF: Beyond MALDI-TOF MS Technology T. Hu, None.

Lyme Disease 2016 Update L. T. Hu, Massbiologics, Research Contractor.


S. Shie: None. P. Huang: None. J. Ye: None. Y. Wu: None. T. Wu:

None. T. Wu: None. S. Chuang: None. M. Cheng: None. C. Huang:

None.


M.D. Huband: Research Contractor; This study and abstract presentation

were funded by a research grant from Wockhardt. D.J. Farrell: Research


grant from Wockhardt. R.K. Flamm: Research Contractor; This study and

abstract presentation were funded by a research grant from Wockhardt.

R.N. Jones: Research Contractor; This study and abstract presentation were

funded by a research grant from Wockhardt.


Listed by Session


the Undergraduate Curriculum L. E. Hughes, None.


G. Huhn: Consultant; Gilead, Viiv.Research Contractor; Gilead, Viiv, Janssen,

BMS. Scientific Advisor (Review Panel or Advisory Committee); Gilead, Viiv. B.

Rijnders: Grant Investigator; Gilead, MSD. Scientific Advisor (Review Panel

or Advisory Committee); Gilead, MSD, ViiV, Pfizer, Jansen-cilag, BMS, Abbvie.

M. Thompson: Investigator; BMS, Gilead, Pfizer, Merck, ViiV. P. Tebas:

Consultant; Merck. Investigator; Gilead. Independent Contractor; Glaxo

(Adjudication committee). P. Shalit: Consultant; Gilead Sciences, Bristol

Meyers-Squibb, Merck, Janssen. Research Relationship; Gilead Sciences,

Janssen, Glaxo Smithkline.Speaker's Bureau; Gilead Sciences, Janssen, Bristol

Meyers-Squibb, Merck. Y. Liu: Employee; Gilead Sciences. T. Nguyen-Cleary:

Employee; Gilead Sciences. M. Das: Employee; Gilead Sciences. S.

McCallister: Employee; Gilead Sciences.

How to Use Behavioral Theories to Design an Effective Antimicrobial

Stewardship Program M. Hulscher, None.


A. Humar, Roche, Qiagen, Astellas, Research Relationship. Chimerix, Roche,

Speaker's Bureau.


Cooperation with the Society of Infectious Diseases Pharmacists (SIDP))

R. M. Humphries, Merck Consultant. Cepheid Consultant. Roche

Consultant. Nanosphere Consultant. GenMark Grant Investigator. Curetis

Grant Investigator. BioMerieux Grant Investigator. BD . Grant Investigator.

Beckman Coulter Grant Investigator.

Literature Review

R. M. Humphries, Merck Consultant. Cepheid Consultant. Roche

Consultant. Nanosphere Consultant. GenMark Grant Investigator. Curetis

Grant Investigator. BioMerieux Grant Investigator. BD . Grant Investigator.

Beckman Coulter Grant Investigator.


Jointly by the Bill & Melinda Gates Foundation) D. Hung, None.

Engaging and Inclusive Teaching in the Microbial Sciences A. Hunter, None.

Antimicrobial Stewardship Success Stories

W. Huskins, Genentech. Scientific Advisor (Review Panel or Advisory

Committee).

Advances in Study Design A. Huttner, None.

Controversies in Antimicrobial Stewardship B. Huttner, None.

Antimicrobial Stewardship Success Stories B. Huttner, None.

Update on the Laboratory Diagnosis of Urinary Tract Infections A. Huttner, None.

Clinical Mycology

T. Gebremariam: None. A. Alqarihi: None. P. Uppuluri: None. N. Azie:

Employee; Astellas Pharma. J. Edwards, Jr.: Consultant; Astellas Pharma.

Scientific Advisor (Review Panel or Advisory Committee); Astellas Pharma.

A.S. Ibrahim: Consultant; Astellas Pharma. Grant Investigator; Astellas

Pharma. Scientific Advisor (Review Panel or Advisory Committee); Astellas

Pharma.

Parasitology and Anti-parasitic Agents T. Ijaz: None. S. Aslam: None. S. Ijaz: None.

Treating Hepatitis B and Hepatitis C in Children G. Indolfi, Alexion Board Member. Gilead, Abbvie, Research Contractor.

Emerging Viral Challenges

M. G. Ison, Biota Consultant. Biota Consultant. Cellex Consultant.

Clarassance Consultant. GlaxoSmithKlein Consultant. GenMarkDx

Consultant. Romark Consultant. Toyama/MediVector Consultant. NexBio

Consultant. Theraclone Consultant. Anolinx Research Relationship. Chimerix

Research Relationship. Gilead Research Relationship. Jansen/Johnson &

Johnson Research Relationship. Astellas Jansen/Vertex.


Listed by Session




Society of Tropical Medicine and Hygiene) R. Izadnegahdar, None.


for Quality Improvement and Clinical Care

J. Jacob, Chair-Elect, Division L, ASM. Board Member. CDC, Grant

Investigator.



Diseases Pharmacists (SIDP)) S. Jang, None.

NIAID Training (T), Career (K), and Fellowship (F) Opportunities G. P. Jarosik, None.




J. Jarvis, I hold an Investigator initiated award from Gilead, Research

Relationship.


Clinical Laboratory A. Jassem, None.

Global Health and Emerging Infections

K. C. Jelden, None. P. C. Iwen, None. J. J. Herstein, None. A. L. Le, None. P.

D. Biddinger, None. C. S. Kraft, None. P. W. Smith, None. A. L. Hewlett,

None. S. G. Gibbs, None. J. J. Lowe, None.




S. Jenkins, Cempra, Bayer, Insmed, Cormedix, Merck, Roche Scientific Advisor

(Review Panel or Advisory Committee).




S. Jenkins, Cempra, Bayer, Insmed, Cormedix, Merck, Roche Scientific Advisor


Clinical Mycology

W. Jeong: None. G.I. Snell: None. B.J. Levvey: None. G.P. Westall: None.

C.O. Morrissey: Scientific Advisor (Review Panel or Advisory Committee);

Advisory board for Merck, Sharp and Dohme (MSD). Received research grants

from Merck, Sharp and Dohme (MSD) and Gilead Sciences; speaker honoraria

from Pfizer. S. Ivulich: None. C.F. Neoh: None. M.A. Slavin: Received

research grants from Merck, Sharp and Dohme (MSD), Pfizer and Gilead

Sciences. D.C.M. Kong: Scientific Advisor (Review Panel or Advisory

Committee); Advisory board for Merck, Sharp and Dohme (MSD) and Pfizer.

Received financial support from Pfizer, Novartis, Merck, Sharp and Dohme

(MSD) and Gilead Sciences.



Significant Bacterial Pathogens R. C. Jerris, None.


D. Jin: None. C. Huang: None. Y. Luo: None. J. Cai: None. W. Fang:

None. X. Wang: None. Y. Tang: None. J. Jiang: None.


Reimbursement, and LOINC Codes C. Johns, None.

Escherichia coli: A Friend or an Enemy?

J. R. Johnson, Crucell/Jannsen, Consultant. Actavis, Grant Investigator.

Merck, Grant Investigator. Tetraphase, Grant Investigator. Duke University

(ARLG), Scientific Advisor (Review Panel or Advisory Committee).


Society of Infectious Diseases Pharmacists (SIDP)) J. Johnson, None.


for Quality Improvement and Clinical Care J. Johnson, None.

Treating Hepatitis B and Hepatitis C in Children

M. Jonas, Gilead Sciences, DSMB, Consultant. Zoll, Spouse/Life Partner,

Employee. Gilead Sciences, Bristol Myers Squibb, Roche, Echosens

Grant Investigator.

Parasitology and Anti-parasitic Agents A.J. Jones: None. M. Kaiser: None. V.M. Avery: None.


Microbiologist M. Jones, None.


Listed by Session

Antimicrobial Breakpoints: Time for a Single CAST? G. O. Kahlmeter, Thermofisher, Consultant.

AST Update: Clinical and Laboratory Impact G. O. Kahlmeter, Thermofisher, Consultant.

Tricky Choices Regarding Appropriate Antimicrobial Prescribing A. C. Kalil, None.


Strategies R.Y. Kao: None. P. Gao: None.

2016 Update on Yaws (Organized In Cooperation with the American

Society of Tropical Medicine and Hygiene) A. Kapa, None.

Endocarditis in 2016 A. W. Karchmer, None.


K. Kaye, Merck, Consultant. Pfizer, Consultant. The Medicines Co.,

Consultant. Achaogen, Consultant. Merck, Grant Investigator. Pfizer,

Grant Investigator. The Medicines Co., Grant Investigator. Pfizer, Speaker's

Bureau.


for Quality Improvement and Clinical Care

K. Kaye, Merck Consultant. Pfizer Consultant. Achaogen Consultant.

Accelerate Grant Investigator. Merck Grant Investigator. Pfizer Grant

Investigator. Pfizer Speaker's Bureau.


M.S. Keckler: None. H. Moulton-Meissner: None. M.M. Lyman: None.

C.T. Grigg: None. C. Bicking Kinsey: None. K.A. Perry: None. N.C.

Toney: None. B. Jensen: None. J. Miller: None. J. Perz: None. K.M.

Perkins: None. M.J. Arduino: None. J. Noble-Wang: None.

Update on the Treatment of HCV/HIV Co-infection A. Kim, None.


Strategies

W. Kim: None. A.L. Conery: None. B.B. Fuchs: None. F.M. Ausubel:

None. E. Mylonakis: None.


Progress Reports H. Kim, None.


D. Kirui: None. G. Weber: None. T. Burton: None. N. Millenbaugh:

None.

Early New Antimicrobial Agents R. Kishii, Kyorin Pharmaceutical Co., Ltd. Employee.

Ethics in Laboratory Medicine R. Klein, None.

Microbiology Research Funding Opportunities K. Klugman, None.




Society of Tropical Medicine and Hygiene) K. Klugman, None.

DIY Microbiomes and Metabolomes R. Knight, None.


Tracking Multi-resistant and Hypervirulent Bacterial Clones S. Kolokotronis, None.



(ICHS))

D. P. Kontoyiannis, Merck Consultant. Astellas Consultant. Astellas

Research Relationship. Merck Research Relationship. Merck, Pfizer, Astellas

Clinical Mycology







N. Mauder: Employee; Bruker Daltonik GmbH. B. Müller: Employee; MVZ

Labor Dessau GmbH. M. Kostrzewa: Employee; Bruker Daltonik GmbH.

M. Wasner: Employee; MVZ Labor Dessau GmbH.

Getting Hired: Job Search Strategies and Crafting Your CV/Resume L. Kozlowski, None.

Advances in Clinical Microbiology from the Horse's Mouth C. S. Kraft, None.


Listed by Session

More Trouble from Ticks in 2016 P. J. Krause, Immunetics, Inc., L2 Diagnostics, Research Contractor.


PulseNet K. A. Kubota, None.

Antimicrobial Stewardship I R. Louis: None. S. Kuhn: None. V. Creswell: None.


E. J. Kuijper, MSD, Biomerieux, Valneva, Pfizer, Astellas. Quiagen, Cubist,

Novartis Spouse/Life Partner, Consultant.

Lyme Disease 2016 Update B. Kullberg, patent, cellular diagnostic test, Lyme disease.

New Frontiers in HIV Cure

D. R. Kuritzkes, Bionor Consultant. Gilead Consultant. GlaxoSmithKline

Consultant. InnaVirVax Consultant. Merck Consultant. ViiV Consultant.

ViroStatics Consultant. Gilead Grant Investigator. Gilead Investigator. Viiv

Investigator. Bionor Investigator. Gilead Research Relationship. Merck

Research Relationship. ViiV Research Relationship.

Broadly Neutralizing Antibodies D. Kwong, None.

Recurrent Fever in Children: Separating the Wheat from the Chaff

H. Lachmann, Novartis Consultant. SOBI Consultant. Takeda Consultant.

Novartis Investigator. SOBI Investigator. Celtic Investigator. Ionis/GSK


Novel Insights into C. difficile Pathogenesis: Toxins and Beyond D. Lacy, Merck, MedImmune, Collaborator.


P. Lagacé-Wiens: None. H. Adam: None. M. Baxter: None. J.

Karlowsky: None. A. Walkty: None. G.G. Zhanel: Research Relationship;

Cubist, Astellas, Merck, Basilea, Pharmascience, The Medicines Company,

Tetraphase, Sunovion.


W. Lainhart: None. L. Mingle: None. M. Dickinson: None. D.

Schoonmaker-Bopp: None. D. Kohlerschmidt: None. E. Nazarian: None.

N. Dumas: None. K. Musser: None.

Advances in Clinical Microbiology from the Horse's Mouth R. Lan, None.

IGRAs for Risk Stratifying Transplant Donors and Recipients C. Lange, None.

GBS Diseases: Global Challenges G. Langley, None.

Who Paves the Way for Fungi: Genes or Doctors? (Organized in

Cooperation with the lmmunocompromised Host Society (ICHS))

F. Lanternier, Basilea Board Member. Gilead, MSD, Novartis Speaker's

Bureau.

Top 10 Papers in Clinical Mycology (Organized in Cooperation with the

Immunocompromised Host Society (ICHS) & European Confederation of

Medical Mycology (ECMM))

C. Lass-Floerl, Pfizer Consultant. Gilead Consultant. Basilea Consultant.

MSD Consultant. Astellas Consultant. Astellas Grant Investigator.

Pfizer Grant Investigator. MSD Grant Investigator. Basilea Scientific Advisor

(Review Panel or Advisory Committee). Gilead Scientific Advisor (Review

Panel or Advisory Committee). MSD Scientific Advisor (Review Panel or

Advisory Committee). Astellas Scientific Advisor (Review Panel or Advisory

Committee).


Clinical Laboratory A. Lau, None.



(CRO/CPO) A. Lau, None.


and Professional Affairs Committee A. Lau, None.

Harmful Effects of Biocide Overuse in Humans and the Environment

(Supported Jointly with the Society for Applied Microbiology (SfAM)) S. Lax, None.

Research Mentor Training for Microbiologists: Part I B. Lazazzera, NSF & ARO Grant Investigator.

Research Mentor Training for Microbiologists: Part II B. Lazazzera, NSF & ARO Grant Investigator.


Listed by Session

Future Microbiology-Predicting the Field in 2026

A. L. Leber, ASCP Member. AMP Member. AMLI Member. BioFire

Diagnositcs Research Relationship. Hologic Research Relationship.

Meridian Research Relationship. Focus Diagnositcs

Research Relationship. Cephid Research Relationship. BioFire Diagnostics



the Hospital and the World

A. L. Leber, ASCP Member. AMP Member. AMLI Member. BioFire

Diagnositcs Research Relationship. Hologic Research Relationship.

Meridian Research Relationship. Focus Diagnositcs

Research Relationship. Cephid Research Relationship. BioFire Diagnostics



the Genomic Era F. Lebreton, None.

Update on Chikungunya Epidemiology, Treatment and Vaccination


Medicine and Hygiene (ASTMH)) M. Lecuit, None.


Y.P. Zhou: None. S.S.L. Tang: None. W. Lee: None. Y.Y. Cai: None. T.P.

Lim: None. M.P. Chlebicki: None. A.L. Kwa: None.

Hot Topics in Antimicrobial Susceptibility Testing M.J. Lee: None. J.A. Hindler: None. R.M. Humphries: None.


J. Lee: None. C. Su: None. S. Chang: None. P. Shu: None. L. Huang:

None.

Getting Hired: Job Search Strategies and Crafting Your CV/Resume K. Lee, None.

Carbapenemases

S.H. Lee: None. K.S. Park: None. J.H. Lee: None. A.M. Karim: None.

M. Park: None. J.H. Kim: None. T.Y. Kim: None.


(PK/PD)

V.H. Lee: None. F. Minhaj: None. J.K. Diep: None. E.J. Ellis-Grosse: A.

Board Member; Zavante Therapeutics, Inc. Employee; Zavante Therapeutics,

Inc. C.S. Abboud: None. A. Forrest: None. G.G. Rao: None.


S.S.L. Tang: None. W.H.L. Lee: None. J. Teo: None. T. Lim: None. M.P.

Chlebicki: None. A.L. Kwa: None.

Predicting the Impact of Antibiotic Stewardship on AMR: Simulations &

Modeling B. Lee, None.


S.T. Lefurgy: None. B. Biju: None. R. Toro: None. V.N. Malashkevich:

None. S.C. Almo: None. K.M. Papp-Wallace: Grant Investigator;

AstraZeneca, Merck, Wockhardt, Actavis. E. Caselli: Employee; Therabor.

F. Prati: Board Member; Therabor. Employee; Therabor. R.A. Bonomo:

Grant Investigator; AstraZeneca, Merck, Actavis, Wockhardt, GSK.


M. Leone, Basilea Scientific Advisor (Review Panel or Advisory Committee).

MSD, Speaker's Bureau.


R. Clifford: None. M. Sparks: None. U. Chukwuma: None. C. Neumann:

None. P. Waterman: None. E. Milburn: None. J. Moran-Gilad: None.

M. Julius: None. M. Hinkle: None. E. Lesho: None.


R. Clifford: None. M. Sparks: None. E. Hosford: None. A. Ong: None.

D. Richesson: None. S. Fraser: None. Y. Kwak: None. S. Miller: None.

M. Julius: None. P. McGann: None. E. Lesho: None.

Antimicrobial Stewardship I G. I. S. Levy Hara, None.

Antimicrobial Stewardship II G. I. S. Levy Hara, None.

Tricky Choices Regarding Appropriate Antimicrobial Prescribing G. I. S. Levy Hara, None.


Cooperation with the Society of Infectious Diseases Pharmacists (SIDP))

J. S. Lewis, Accelerate Diagnostics, Allergan, Astellas, Medicines Co, Merck



Convention

K. Lewis, Novobiotic Pharmaceuticals Board Member. Arietis Board

Member.


Listed by Session



K. Lewis, Novobiotic Pharmaceuticals Board Member. Arietis Board

Member.

Clinical Update on Hepatitis S. LHomme, None.

PK/PD Optimization against Carbapenamase Producing Bacteria J. Li, Rempex Pharmaceuticals, Collaborator.

Novel Vaccines: From Basic Research Through Clinical Development J. Liao: None. D.R. Smith: None. P.I. Watnick: None.




M. D. Libman, Pfizer Scientific Advisor (Review Panel or Advisory

Committee).

Epidemiology and Control of Nosocomial MDRO J. Liese: None. A. Dinkelacker: None.

Management of Cytomegalovirus A. P. Limaye, Merck Consultant. Astellas Grant Investigator. Genentech.

Infectious Disease Quiz A. P. Limaye, Merck Consultant. Astellas Grant Investigator. Genentech.


Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) B. Limbago, None.



(CRO/CPO) B. Limbago, None.


A Cases Based Discussion B. Limbago, None.


Discovery W. I. Lipkin, None.

Antimicrobial Stewardship Success Stories J. Lipman, None.

Early New Antimicrobial Agents T. Lister, IHMA, Inc., Independent Contractor.


S. Mushtaq: None. A. Vickers: None. N. Woodford: Research Contractor;

Achaogen, Accelerate, Allecra, Amplex, AstraZeneca, Becton Dickinson, Meiji,

Roche, Wockhardt. D.M. Livermore: Consultant; Accelerate, Achaogen,

Adenium, Alere, Allecra, Altermune, Astellas, AstraZeneca, Auspherix, Basilea,

Bayer, BioVersys, Cubist, Cycle, Discuva, GSK, Nordic, Meiji, Pfizer, Roche,

Shionogi, Tet.Research Contractor; Roche, Melinta, Tetraphase, Wockhardt,

Meiji,. K. Shareholder (excluding diversitied mutual funds);

Merck, Dechra, Pfizer, Perkin Elmer, GSK.Speaker's Bureau; AOP Orphan,

Astellas, AstraZeneca, Curetis, Merck, Pfizer.


Genomic Era M. J. Llewelyn, Genentech Consultant. Pfizer Consultant. Astellas Consultant.


Infectious Diseases Society (PIDS)) S. S. Long, None.

Recurrent Fever in Children: Separating the Wheat from the Chaff S. S. Long, None.

Infectious Disease Quiz S. S. Long, None.

Science in 30 Seconds: Develop an Elevator Speech K. Lontok, None.

How Can I Put This?: Creating Analogies K. Lontok, None.

Once Upon a Time, in a Lab Far Away?: Telling Your Science as a Story K. Lontok, None.


(PK/PD)

C. Lu: Employee; Roche R&D Center China Ltd. Y. Zhang: None. M. Chen:

None. P. Zhong: None. J. Wu: None. Y. Zhang: None. J. Zhang: None.


Cardiopulmonary Bypass Surgery: Investigation of an Outbreak M. Lyman, None.

Early New Antimicrobial Agents Z. Ma, None.

Foundations to Frontiers: The Molecular Revolution L. Ma, None.


Listed by Session


(PK/PD)

A. MacGowan, Merck, Clinigen, Achaeogen,AiCuris,Tetraphase, Grant

Investigator. Aicuris, Micron Research Research Relationship. Trustee

Showering Fund.

Antimicrobial Stewardship II S.H. MacVane: None. L.L. Steed: None.


P.J. Maddon: Board Member; Progenics Pharmaceuticals, Inc.. Consultant;

CytoDyn Inc.. K. Shareholder (excluding diversitied mutual funds) Progenics

Pharmaceuticals, Inc. and CytoDyn Inc.. M. Independent Contractor; CytoDyn

Inc. K. Dhody: Employee; Amarex Clinical Research, LLC. U. Kowalczyk:

Employee; Quest Clinical Research. K. Kazempour: A. Board Member;

Amarex Clinical Research, LLC. Employee; Amarex Clinical Research, LLC. K.

Shareholder (excluding diversitied mutual funds); Amarex Clinical Research,

LLC. N. Pourhassan: Board Member; CytoDyn Inc.. Employee; CytoDyn

Inc. Shareholder (excluding diversitied mutual funds); CytoDyn Inc. J.

Lalezari: Employee; Quest Clinical Research.

Hot Topics in Antimicrobial Susceptibility Testing M. Maiden: None. A. Hunt: None. C. Waters: None.


(Supported Jointly with the Society for Applied Microbiology (SfAM)) J. Maillard, Biocide consult Ltd. Independent Contractor.


Pathologie Infectieuse de Langue Française (SPILF)) A. Mailles, None.

Zika Virus: An Emerging Threat M. Majumder, None.

Clinical Virology

A. Wald, Vical Incorporated Investigator. A. S. Magaret, Vical Incorporated

Investigator. T. J. Warren, Vical Incorporated Investigator. N. Van

Wagoner, Vical Incorporated Investigator. J. D. Kriesel, Vical Incorporated

Investigator. S. K. Tyring, Vical Incorporated Investigator. K. H. Fife, Vical

Incorporated. Investigator. D. J. Seiden, Vical

Incorporated Investigator. L. R. Smith, Vical Incorporated Employee. M. P.

Mammen, Vical Incorporated Employee.


N. Mamuchishvili: None. K. Zakhashvili: None. D. Echeverria: None. N.

Heyer: None. P. Imnadze: None.

Bioinformatic Tools for WGS-based Typing of MDR Bacteria S. Mande, None.

IGRAs for Risk Stratifying Transplant Donors and Recipients O. Manuel, Lophius, Qiagen, Grant Investigator.



Medicine and Hygiene (ASTMH)) S. Marais, None.

GBS Diseases: Global Challenges I. Margarit Y Ros, Glaxo Smith Kline Employee.

2016 Update on Yaws (Organized In Cooperation with the American

Society of Tropical Medicine and Hygiene) M. Marks, None.


for Quality Improvement and Clinical Care E. M. Marlowe, None.

Let's Talk about Sex! STIs and the Challenges of Diagnosis and Treatment

J. Marrazzo, Symbiomix; Curatek Research Contractor. AstraZeneca; Merck

Research Relationship. Cepheid Scientific Advisor (Review Panel or


Effective and High Impact Scientific Writing S. Marriott, BioScience Writers Employee.


to Treating Bacterial Infections J. L. Martin, None.

At the Intersection of Art and Microbiology M. O. Martin, None.

Making an Impact: Utilization and Outcomes in the Microbiology Lab

R. Martinez, BioFire Diagnostics Grant Investigator. BioFire Diagnostics


New Frontiers in HIV Cure

J. Martinez-Picado, Gilead, Merck Consultant. ViiV, Merck, Gilead Grant

Investigator.


Listed by Session


F. M. Marty, Alexion Consultant. Astellas Consultant. Chimerix

Consultant. Fate Therapeutics Consultant Gilead Consultant.

GlaxoSmithKline Consultant. LFB

Consultant. Merck Consultant. Shire Consultant. Ansun Investigator.

Astellas Investigator. Chimerix Investigator. Gilead Investigator. Shire

Investigator. WHISCON Investigator.



(CRO/CPO) A. Mathers, None.


A.C. Ong: None. P. Mc Gann: None. R. Maybank: None. E. Snesrud:

None. Y.I. Kwak: None. R.J. Clifford: None. M. Hinkle: None. E. Lesho:

None.


A. J. McAdam, Bacterioscan Inc. Scientific Advisor (Review Panel or Advisory

Committee).

Advances in Clinical Microbiology from the Horse's Mouth

A. J. McAdam, Bacterioscan Inc. Scientific Advisor (Review Panel or



Y.P. Tabak: Employee; BD. C.A. DeRyke: Employee; Merck & Co. Inc. V.

Gupta: Employee; BD. D.D. DePestel: Employee; Merck & Co. Inc. S.S.

Sen: Employee; Merck & Co. Inc. X. Sun: Employee; BD. R.S. Johannes:

Employee; BD. E. McCann: Employee; Merck & Co. Inc.




Society of Tropical Medicine and Hygiene) E. D. Mccollum, None.

What?s New with Varicella

J. E. McElhaney, Site Investigator GSK zoster vaccine trial Grant Investigator.

GSK Publication Steering Committee and Advisory Panel Scientific Advisor


Microbiology Research Funding Opportunities J. J. McGowan, None.


Communication M. Mckenna, None.


E.A. McMillan: None. S.K. Gupta: None. L. Williams: None. T. Jove:

None. C.R. Jackson: None. M. McClelland: None. J.G. Frye: None.


(Supported Jointly with the Society for Applied Microbiology (SfAM)) P. McNamara, None.

How to Change the Reporting of Microbiology Results to Improve

Antibiotic Prescribing (Organized in Cooperation with the Society of

Infectious Diseases Pharmacists (SIDP))

C. McNulty, author of antibiotic guidance in primary care Consultant.

NICE advisory committee, Scientific Advisor (Review Panel or Advisory

Committee).

More Trouble from Ticks in 2016 P. Mead, None.

New insights into Urinary Tract Infections J. Meddings, None.


(PK/PD)

J. Meletiadis: Grant Investigator; Astellas, Gilead, MSD, Pfizer. E.

Taconelli: None. G. De Angelis: None. G. Restuccia: None. L. Preotescu:

None. M. Popoiu: None. B. Carevic: None. T. Tosic: None. Y. Carmeli:

None. A. Lernar: None. A. Adler: None. S. Percia: None. H. Goosens:

None. S. Malhotra-Kumar: None. C. Lammens: None. J. Mouton:

None.


All A. Mellmann, None.


K. Mendoza: None. R.B. Thomson: None. D. Schora: None. L.M.

Sabatini: None. L.R. Peterson: None.

Parasitology and Anti-parasitic Agents H. Mengist: None.


D. K. Mercer, NovaBiotics Ltd Employee. D. J. Fraser-Pitt, NovaBiotics Ltd

Employee. J. Robertson, NovaBiotics Ltd Employee. D. A. O'Neil,

NovaBiotics Ltd Board Member.

NovaBiotics Ltd Shareholder (excluding diversitied mutual funds).


Listed by Session

Engaging and Inclusive Teaching in the Microbial Sciences S. Merkel, None.

Foundations to Frontiers: The Molecular Revolution J. Messing, None.

At the Intersection of Art and Microbiology M. Middleton, None.

New Antifungals

L. Miesel: Employee; Eurofins Panlabs, Ltd..Research Contractor; Cidara

Therapeutics, Inc. K.Y. Lin: Employee; Eurofins Panlabs, Ltd..Research

Contractor; Cidara Therapeutics, Inc. J.C. Chien: Employee; Eurofins

Panlabs, Ltd..Research Contractor; Cidara Therapeutics, Inc. M.L. Hsieh:

Employee; Eurofins Panlabs, Ltd..Research Contractor; Cidara

Therapeutics, Inc. V. Ong: Employee; Cidara Therapeutics, Inc. K.

Bartizal: Employee; Cidara Therapeutics, Inc.

Carbapenemases

A. Piazza: None. I. Bitar: None. M. Caltagirone: None. E. Nucleo: None.

M. Spalla: None. F. Novazzi: None. E. Oliva: None. P. Pedroni: None.

R. Migliavacca: None. L. Pagani: None.


L.A. Mike: None. S.N. Smith: None. C. Sumner: None. H.L.T. Mobley:

None.


PulseNet

M. Miller, Meridian Biosciences Consultant. Hologic Investigator. Luminex

Corp., Investigator. Cepheid Investigator. Cepheid Scientific Advisor



and Professional Affairs Committee

M. Miller, Meridian Biosciences Consultant. Hologic Investigator. Luminex

Corp., Investigator. Cepheid Investigator. Cepheid Scientific Advisor





K. H. Mills, Consultant to DYNAVAX. Novartis/ GSK vaccines. Research

Contractor.


M. Modi: None. K. Madhavani: None. N. Patel: None. S. Nanda: None.

T. Javadekar: None.


S.B. Mohamed-Yussof: None. A.L.V. Melok: None. T. Chu: None. L.H.

Lee: None.


M.F. Mojica: None. K.M. Papp-Wallace: Grant Investigator; AstraZeneca,

Actavis, Merck, Wockhardt. M.R. Jacobs: Grant Investigator; Wockhardt,

AstraZeneca, Actavis. J.J. LiPuma: Grant Investigator; AstraZeneca, Actavis.

R.A. Bonomo: Grant Investigator; AstraZeneca, Actavis, Merck, Wockhardt,

GSK.

Literature Review

J. Molina, Gilead Sciences, MSD, ViiV, Bristol Myzers Squibb. Board

Member. Gilead Grant Investigator. Gilead Speaker's Bureau.



Gynecology (IDSOG)) D. Money, None.

Biosafety and Biosecurity Lessons to Be Learned S. Monroe, None.

Global Health and Emerging Infections S. Moon, None.

The Human Microbiome as a Reservoir of Antimicrobial Resistance Genes A. M. Moore, None.

Fecal Transplantation for Clostridium difficile Infection T. A. Moore, None.





S. Moore, Lupin Pharmaceuticals, Consultant. Glycosyn Health Initiatives,

Investigator.


Cardiopulmonary Bypass Surgery: Investigation of an Outbreak H. Moulton-Meissner, None.



Diseases Pharmacists (SIDP)) B. Mueller, Merck, Theravance Grant Investigator.


Listed by Session

Parasitology and Anti-parasitic Agents I. Mugerwa: None.


(PK/PD) A. Muller, None.

Management of Cytomegalovirus N. Müller, None.



(CRO/CPO)

S. Munoz-Price, Xenex Scientific Advisor (Review Panel or Advisory

Committee). Clorox, Ecolab Speaker's Bureau.

Clinical Applications of Next Generation Sequencing J. Musser, None.


the Undergraduate Curriculum T. R. Muth, None.


A.W. Mwongula: None. L.A. Mwamburi: None. M. Mwau: None. D.N.

Siamba: None. F.W. Wanyama: None.


Microbiologist D. Myers, None.


N. Nachimuthu: None. A. Ballard: None. F. Reid: None. H. Nguyen:

None. A. Sirajuddin: None. J. Butler: None. J. Katz: None. L.

Ostrosky: Consultant; Astellas, Merck, Scynxis, Cidara. Grant Investigator;

Merck, Astellas, Pfizer, Scynexis, T2 Biosystems, Meiji, Immunetics.Speaker's

Bureau; Merck, Pfizer.

ID Fellows 101: For Fellows Age 18-88

S. Naggie, HaborPath Board Member. BMS, Gilead Science Grant

Investigator. IDSA Merck Member. Abbvie, BMS, Gilead Science, Janssen

Pharmaceuticals, Merck, Tacere, Vertex Pharmaceuticals Research

Relationship. Eviral Hep, IAS-USA, Mentor Meetings, Platform Q Health Inc.,

Practice Point Communications.

Hand Hygiene and Environmental Issues in the Healthcare Setting I. Nakamura: None. T. Matsumoto: None.


Tracking Multi-resistant and Hypervirulent Bacterial Clones A. Narechania, None.



Anti-Infective Pharmacology (ISAP)) R. L. Nation, None.


International Society of Anti-Infective Pharmacology (ISAP)) R. L. Nation, None.

Front-end Automation in the Clinical Microbiology Laboratory L. Navarria: None. A. Giambra: None. S. Castriciano: None.



(ICHS)) M. Netea, None.


Cooperation with the Pediatric Infectious Diseases Society (PIDS))

J. Newland, RPSdiagnostics Consultant. Pfizer

Grant Investigator.


the Undergraduate Curriculum J. Newman, None.

Clinical Mycology

M. Nguyen: None. R. Rivosecchi: None. R. Shields: None. B. Falcione:

None. C. Ensor: None. V. Venkataramanan: None. A. Humar: None.

C. Clancy: None.


K.A. Nichol: None. H.J. Adam: None. G.R. Golding: None. M.

McCracken: None. M.R. Baxter: None. J.A. Karlowsky: None. D.J.

Hoban: Research Relationship; Astellas, Basilea, Merck,

Abbott, Pharmascience, Sunovion, Tetraphase, The Medicines Company,

Cubist. G.G. Zhanel: Research Relationship; Astellas, Basilea, Merck,

Pharmascience, Sunovion, Tetraphase, The Medicines Company, Cubist.




D. P. Nicolau, AstraZeneca, Merck, Pfizer, Roche, Tetraphase Consultant.

Merck, Pfizer, Roche, Shionogi, Tetraphase Grant Investigator.


Listed by Session


C.A. Sutherland: None. J.E. Verastegui: None. D.P. Nicolau: Speaker's

Bureau; Bayer.

When the Standard PK/PD Model Does not Apply E. Nielsen, F. Hoffmann-La Roche Ltd Research Relationship.


International Society for Chem apy for Infection and Cancer) Y. Nishiuchi, None.

Escherichia coli : A Friend or an Enemy?

P. Nordmann, Antabio Scientific Advisor (Review Panel or Advisory

Committee). Allecra Scientific Advisor (Review Panel or Advisory

Committee).

From Phenotype to Molecular Detection: The Case of Carbapenemases

P. Nordmann, Antabio Scientific Advisor (Review Panel or Advisory

Committee). Allecra Scientific Advisor (Review Panel or Advisory

Committee).

Hot Topics in Antimicrobial Susceptibility Testing N. noureen: None.

Parasitology and Anti-parasitic Agents

S. Nuralitha: None. J.E. Siregar: None. D. Syafruddin: None. S. Marzuki:

None. A.I.M. Hoepelman: None.


Cooperation with the Pediatric Infectious Diseases Society (PIDS))

J. Nuttall, Glaxo Smith Kline Southern Africa Advisory Board: Understanding

the most appropriate pediatric dosing formulations for HIV positive pediatric

patients in Africa Scientific Advisor (Review



in Gram-positive Bacteria A.S. Nuxoll: None. K. Lewis: None.

Emerging Viral Infections S. Oberste, None.

Parasitology and Anti-parasitic Agents A. R. Odom, None.

Broadly Neutralizing Antibodies E. Ollmann Saphire, None.

Forty Years after the Double Bind M. Ong, None.


D. Ono: None. T. Yamaguchi: None. M. Hamada: None. Y. Ishii: None.

K. Tateda: None.


I.O.M. Op den Buijs: None. R.T.J.M. Roymans: None. J.T.W. Nijs: None.

L. van Dommelen: None. I.T.M.A. Overdevest: None. J.H.B. van de

Bovenkamp: None.

Lights, Camera, Science! Engaging Videos 101 R. Ortega, None.




L. Ostrosky-Zeichner, MSG-ERC Board Member. Astellas Consultant.

Cidara Consultant. MSG-ERC Consultant. Astellas Grant Investigator.

T2 Biosystems Grant Investigator. Scynexis Grant Investigator.

Immunetics Grant Investigator. Pfizer Grant Investigator. Merck Grant

Investigator. Meiji Grant Investigator. Janssen Grant Investigator. Merck

Scientific Advisor (Review Panel or Advisory Committee). T2 Biosystems

Scientific Advisor (Review Panel or Advisory Committee). Cidara

Scientific Advisor (Review Panel or Advisory Committee). Xenex Scientific

Advisor (Review Panel or Advisory Committee). Scynexis Scientific Advisor

(Review Panel or Advisory Committee). Merck Speaker's Bureau. Pfizer

Speaker's Bureau.

Future Microbiology-Predicting the Field in 2026 K. Ota Sullivan, None.

Pediatric Microbiology for Clinicians and Laboratorians K. Ota Sullivan, None.


S. Otani: None. H. Takoi: None. K. Fujita: None. M. Gorai: None. R.

Okuda: None. Y. Mano: None. K. Matsuda: None. Y. Saito: None. A.

Gemma: None. N. Furuya: None.

Foundations to Frontiers: The Molecular Revolution N. R. Pace, None.

More Trouble from Ticks in 2016 C. D. Paddock, None.

Antimicrobial Discovery Approaches

M. Page, Basilea Pharmaceutica International Ltd Shareholder (excluding



Jointly by the Bill & Melinda Gates Foundation)

M. Page, Basilea Pharmaceutica International Ltd Shareholder (excluding



N. Palavutitotai: None. A. Jitmuang: None. S. Tongsai: None. P. Kiratisin:

None. N. Augkasekwinai: None.


Listed by Session

Maurice Hilleman Award Lecture: Towards a Universal Influenza Virus

Vaccine

P. Palese, GSK is providing research funds for developing a universal

influenza virus vaccine, Research Contractor. Mount Sinai has submitted

patents in the area of a universal influenza virus vaccine


the Genomic Era K. Palmer, Cubist Pharmaceuticals Grant Investigator.

Top 10 Beta-lactamase Papers for 2015 T. G. Palzkill, Synthetic Biologics Consultant.


D. Pantazatos: None. E. Mavridou: None. S. Thirumuruganandham:

None. M. Tirion: None. T.J. Walsh: None.


C.R. Bethel: None. K.M. Papp-Wallace: Grant Investigator; Wockhardt,

Merck, AstraZeneca, Actavis. M.D. Barnes: None. R.A. Bonomo: Grant

Investigator; Wockhardt, Merck, AstraZeneca, Actavis, GSK.

At the Intersection of Art and Microbiology S. Park, None.



Medicine and Hygiene (ASTMH)) P. Parola, None.

Early New Antimicrobial Agents

T. Parr, Spero Therapeutics Employee. Fedora Pharmaceuticals



Convention T. Parr, Spero Therapeutics Consultant.


to Treating Bacterial Infections T. Parr, Spero Therapeutics Employee.


International Society for Chem apy for Infection and Cancer) N. Parrish, None.

Clinical Mycology

N. Pettit: None. M. Miceli: None. C. Rivera: None. A. Perissinotti:

None. M. Hsu: None. P. Narayanan: None. J. Pisano: Scientific Advisor

(Review Panel or Advisory Committee); Astellas. S. Seo: None. A.

Paskovaty: None.


M.E. Patch: None. K. Napholz: None. F. Cioffi: None. M. Saunders:

None. S. Estrada: Consultant; T2 Biosystems.


Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) J. B. Patel, None.


P. Patel: None. R. Thomson: None. L. Peterson: None. K. Mangold:

None. S. Das: None.


Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) J. B. Patel, None.

Discovery to Implementation: What We Need to Get New Drugs and

Diagnostics for Antibiotic Resistant Infections J. B. Patel, None.

Novel Strategies to Help Antibiotics to Play their Role M. B. Patel, None. G. W. Gokel, None.

Carbapenemases

M. Patel: None. V. Stojanoski: None. C. Adamski: None. B. Fryszczyn:

None. T. Palzkill: None.


Resistance - A Formidable Foe R. Patel, None.

Literature Review D. Paterson, None.

Infectious Disease Quiz D. Paterson, None.


M. Pathiraja: None. E. Mckle: None. N. Damani: None. E. Porter:

None. A. McCorry: None. K. Hopkins: None. J. Turton: None.

Controversies in Antimicrobial Stewardship M. Paul, None.

Tricky Choices Regarding Appropriate Antimicrobial Prescribing M. Paul, None.

Escherichia coli : A Friend or an Enemy? G. Peirano, None.

Infectious Disease Quiz A. Y. Peleg, None.


Listed by Session

Biosafety and Biosecurity Lessons to Be Learned M. A. Pentella, None.

Myths in Infection Control E. N. Perencevich, Merck & Co., Inc. Grant Investigator.


& Adolescent

S. A. Pergam, Merck Consultant. Merck, Chimerix, Cubist Research

Relationship.


(Supported jointly by IDSA and AMSMIC) E. Peter V. Chin-Hong, None.





W. A. Petri, Perrigo Nutritionals Consultant. TechLab, Inc Consultant.

Seres Therapeutics Consultant.

AST Update: Clinical and Laboratory Impact

C. Petti, Ancestry Employee. Pathogenomix Scientific Advisor (Review


Control of Nosocomial Influenza Transmission: What Have We Missed?

V. Philippe, GSK Scientific board In France, Board Member. BIOMERIEUX

Consultant. SANOFI PASTEUR, ANIOS Research Relationship.

Early New Antimicrobial Agents P. Picconi, None.

Pediatric Microbiology for Clinicians and Laboratorians B. Pinsky, None.


D. Pires: None. H. Soule: None. F. Bellissimo-Rodrigues: None. A.

Gayet-Ageron: None. D. Pittet: None.

Nosocomial Outbreaks D. Pittet, None.

ICAAC Lecture: Clean Hands Save Lives: Worldwide Perspectives D. Pittet, None.


Tracking Multi-resistant and Hypervirulent Bacterial Clones P. J. Planet, None.

Bioinformatic Tools for WGS-based Typing of MDR Bacteria P. J. Planet, None.

Models and Technologies for Studying Pathogenesis P. J. Planet, None.

Error Rates in Clinical Microbiology Laboratories: Where Do We stand? M. Plebani, None.

Escherichia coli : A Friend or an Enemy? L. Poirel, None


L. Poirel: None. N. Kieffer: None. A. Brink: None. J. Coetze: None.

P. Nordmann: None.


and Nosocomial Superbugs (Joint ASM-FEMS Symposium) L. Poirel, None


A Cases Based Discussion L. Poirel, None


Infectious Diseases Society (PIDS)) A. J. Pollard, None.



Infectious Diseases Society (PIDS)) A. J. Pollard, None.

Emerging Viral Infections N. R. Pollock, None.

Alexander Fleming and the Beginnings of Biofilm Research J. A. Poupard, None.

Carbapenemases

D. De Belder: None. B. Ghiglione: None. G. Gutkind: None. F.

Pasterán: None. M.M. Rodríguez: None. A. Corso: None. S. Gómez:

None. P. Power: None.


A. L. Pozniak, Clinical Trials for BMS, Merck,Gilead and ViiV, Investigator.

Advisory board Janssen, BMS, Merck,Gilead and ViiV, Scientific Advisor

(Review Panel or Advisory Committee). Gilead Speaker's Bureau. EACS

and BHIVA Guidelines committeees

Antimicrobial Resistance Control: A One-Health Approach L. Price, None.

Global Health and Emerging Infections B. S. Pritt, None.

More Trouble from Ticks in 2016 B. S. Pritt, None.


Listed by Session

Course in Medical Mycology

G. Procop, bioMerieux Grant Investigator. Hardy Diagnostics Grant

Investigator. Bruker Grant Investigator. Qiagen Grant Investigator.

Hologics Grant Investigator.

Antimicrobial Stewardship I C. Pulcini, None.

Controversies in Antimicrobial Stewardship C. Pulcini, None.

Antimicrobial Resistance Control: A One-Health Approach C. Pulcini, None.

Microbiology in the World of Social Media V. Racaniello, None.



M. Rahman: None. S.V. Nguyen: None. K.A. McCullor: None. C.J. King:

None. J.H. Jorgensen: None. W.M. Mcshan: None.


Convention

L. G. Rahme, Spero Therapeutics Shareholder (excluding diversitied mutual

funds).


J.C. Ramos: None. J.R. Arribas: None. F. Arnalich: None. J. Garcia:

None. J. Mingorance: None. R. Herruzo: None. G. Ruiz: None. A.

Borobia: None. F. Lázaro: None. J.R. Paño: None.

Myths in Infection Control D. Raoult, None.


Diagnostics for Antibiotic Resistant Infections A. Ratcliffe, None.


Cooperation with the Pediatric Infectious Diseases Society (PIDS)) A. Ratner, None.

Hot Topics in Antimicrobial Susceptibility Testing C. Rauch, None.


Qualitative Research for Dummies J. Redfern, None.

Forty Years after the Double Bind E. Reuben, None.

Antimicrobial Stewardship II C. Reuter: None. T. Hudson: None. C. Nguyen: None. J. Li: None.

Practical Project Management for Scientists R. Ribaudo, None.


K. Timm: None. E.M. Richards: None. M. Dodd: one. K. Culbreath:

None.

Primer on Transplantation C. Richardson, None.

Integration of MALDI-TOF MS in Clinical Laboratories-Two Laboratories'

Experiences

S. Richter, bioMerieux Research Relationship. BD Diagnostics Research

Relationship.

Control of Nosocomial Influenza Transmission: What Have We Missed? J. Ridgway, None.


Society of Infectious Diseases Pharmacists (SIDP))

S. Riedel, Planet Innovation Consultant. Centers of Disease Control &

Prevention (CDC), Goncoccal Isolate Surveillance Program (GISP) Grant

Investigator. CAP Microbiology Resource Committee Member. JMI

Laboratories, Liberty, IA Research Relationship. OpGen, Inc. ; UK General

Medical Research Council Scientific Advisor (Review Panel or Advisory

Committee). Becton, Dickinson & Co. Speaker's Bureau.

Epidemiology and Control of Nosocomial MDRO F. Ramos: None. M. Rigatto: None. A. Zavascki: None.


Reimbursement, and LOINC Codes A. Riley, None.

Escherichia coli : A Friend or an Enemy?

L. W. Riley, Silver Lake Research Corp Collaborator. Silver Lake Research

Corp Research Relationship.


T. Riley, Merck Investigator. Alere Research Relationship. Merck Scientific

Advisor (Review Panel or Advisory Committee). Sanofi Scientific Advisor


Forty Years after the Double Bind L. Rissler, None.

Clinical Mycology

C.R. Ensor: None. B.A. Falcione: None. R. Venkataramanan: None. M.

Nguyen: None.


J. A. Roberts, Infectopharm Board Member. MSD Grant Investigator.

MSD Speaker's Bureau.

The Human Microbiome as a Reservoir of Antimicrobial Resistance Genes A. P. Roberts, None.


Listed by Session



Environment B. Robinson-Dunn, None.

Update on the Laboratory Diagnosis of Urinary Tract Infections B. Robinson-Dunn, None.


J. Rodríguez-Baño, Roche Consultant. Merck Consultant. Achaogen

Consultant. AstraZeneca Consultant. Pfizer Consultant. Basilea

Consultant. InfectoPharm

Consultant. Innovative Medicines Initiative Research Relationship.

.


A Cases Based Discussion

J. Rodríguez-Baño, Roche Consultant. Merck Consultant. Achaogen

Consultant. AstraZeneca Consultant. Pfizer Consultant. Basilea

Consultant. InfectoPharm

Consultant. Innovative Medicines Initiative Research Relationship.


E. Recacha: None. J. Machuca: None. P. Diaz de Alba: None. M. Ramos

Güelfo: None. F. Docobo Perez: None. J. Rodriguez Beltran: None. J.

Blazquez: None. A. Pascual: None. J. Rodriguez-Martinez: None.



(ISAP))

K. A. Rodvold, Rempex/Medicine Company Consultant. Rempex/Medicine

Company; Tetraphase Scientific Advisor (Review Panel or Advisory

Committee). Medicine Company; Merck/Cubist Speaker's Bureau.



Diseases Pharmacists (SIDP))

K. A. Rodvold, Rempex/Medicine Company Consultant. Rempex/Medicine

Company; Tetraphase Scientific Advisor (Review Panel or Advisory

Committee). Medicine Company; Merck/Cubist Speaker's Bureau.

Interplay between Antimicrobial Resistance and Bacterial Persistence N. Role, None.


Infectious Diseases Society (PIDS)) N. Role, None.

Cases in Clinical Microbiology N. Role, None.




Society of Tropical Medicine and Hygiene) N. Role, None.

When the Standard PK/PD Model Does not Apply N. Role, None.

Surveillance for the 21st Century N. Role, None.


(Supported Jointly with the Society for Applied Microbiology (SfAM)) N. Role, None.


International Society of Anti-Infective Pharmacology (ISAP)) N. Role, None.

Resistance Surveillance and Public Health N. Role, None.

Emerging Viral Challenges N. Role, None.

President's Forum - Viruses: Vital Members of Polymicrobial

Communities M. Roossinck, None.



M. Fatouraei: None. M. Martinez Moral: None. M. Roch: None. I. Yun:

None. W. Rose: None. A.E. Rosato: None.

Tricky Choices Regarding Appropriate Antimicrobial Prescribing W. Rottier, Merck Sharp & Dohme Grant Investigator.


& Adolescent C. E. Rubens, None.

Microbiology Career Choices: What's Available and How to Succeed L. J. Runyen-Janecky, None.


Listed by Session

NIAID Training (T), Career (K), and Fellowship (F) Opportunities L. Rust, None.

Tips for Writing Grant Applications L. Rust, None.

HIV Cohorts Studies

C. Sabin, ViiV Healthcare, Janssen-Cilag, Gilead Sciences Scientific Advisor

(Review Panel or Advisory Committee). Gilead Sciences Speaker's Bureau.

Preparation of educational materials for: ViiV Healthcare, Gilead Sciences,

Janssen-Cilag


H. S. Sader, JMI Laboratories, Inc. has also received research and educational

grants in 2014-2015 from Achaogen, Actavis, Actelion, Allergan, American

Proficiency Institute (API), AmpliPhi, Anacor, Astellas, Research Contractor.

AstraZeneca, Basilea, Bayer, BD, Cardeas, Cellceutix, CEM-102

Pharmaceuticals, Cempra, Cerexa, Cidara, Cormedix, Cubist, Debiopharm,

Dipexium, Dong Wha, Durata, Enteris, Exela Research Contractor. Forest

Research Institute, Furiex, Genentech, GSK, Helperby, ICPD, Janssen, Lannett,

Longitude, Medpace, Meiji Seika Kasha, Melinta, Merck, Motif, Nabriva,

Novartis, Paratek, Pfizer, Pocared, Research Contractor. PTC Therapeutics,

Rempex, Roche, Salvat, Scynexis, Seachaid, Shionogi, Tetraphase, The

Medicines Co., Theravance, ThermoFisher, VenatoRX, Vertex, Wockhardt,

Zavante.


Convention H. Sahl, None.

Biosafety and Biosecurity Lessons to Be Learned R. Salerno, None.

Global Health and Emerging Infections R. Salerno, None.



Environment M. Salfinger, None.


Society of Infectious Diseases Pharmacists (SIDP)) M. Salfinger, None.


the Hospital and the World S. Salipante, None.

Predicting the Impact of Antibiotic Stewardship on AMR: Simulations &

Modeling M. H. Samore, None.


D. Sampat: None. A. Wanger: None. G. Holzmann-Pazgal: None. J.

Butler: None. N. Thosani: None. L. Ostrosky-Zeichner: None.

Error Rates in Clinical Microbiology Laboratories: Where Do We stand? L. P. Samuel, None.

Cases in Clinical Microbiology M. Sanguinetti, None.

Antimicrobial Stewardship II P. Scapellato, None.

GBS Diseases: Global Challenges J. Schlom, None.


Microbiology Educator (Supported jointly by IDSA and AMSMIC) M. G. Schmidt, None.


(Supported jointly by IDSA and AMSMIC) M. G. Schmidt, None.


E.K. Schneider: None. M. Azad: None. Q. Zhou: None. J. Wang: None.

J. Huang: None. M. Cooper: None. Y. Doi: None. M. Muller: None.

J. Li: None. T. Velkov: None.


D.M. Schora: None. B. Smith: None. A. Robicsek: None. R.B. Thomson:

None. L.R. Peterson: Consultant; Consultant with Cepheid and Roche.

Research Relationship; Research Grants with BD, Cepheid and

Roche.

Clinical Virology

G. Schrank: None. J. Gandhi: None. I.E. Stillman: None. M.

McMasters: None. C.S. Tan: None.

Antimicrobial Stewardship in Hospitals J. Schrenzel, Abbott; bioMérieux, Debiopharm Research Contractor.


Listed by Session


Strategies

R. Schuch: Employee; ContraFect Corporation. J. Oh: Employee; ContraFect

Corporation. M. Wittekind: Employee; ContraFect Corporation.



Significant Bacterial Pathogens A. N. Schuetz, None.


Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) A. N. Schuetz, None.

Emerging Viral Challenges S. Schultz-Cherry, None.


Microbiology Educator (Supported jointly by IDSA and AMSMIC) B. S. Schwartz, None.


(Supported jointly by IDSA and AMSMIC) B. S. Schwartz, None.

Novel Vaccines: From Basic Research Through Clinical Development R. Seedarnee: None. M. Baer: None. D. Bucher: None.


Discovery J. Segre, None.


in Clinical and Public Health Microbiology J. Segre, None.


M. Roche: None. C. Bornet: None. P. Monges: None. A. Stein: None.

S. Gensollen: None. P. Seng: None.

Clinical Mycology

J. Sexton: None. B. Tegtmeier: None. J. Ito: Speaker's Bureau; Astellas,

Merck. S. Dadwal: None. J. Kriengkauykiat: None.


Cooperation with the Pediatric Infectious Diseases Society (PIDS)) S. S. Shah, None.

Forty Years after the Double Bind A. Shaw, None.


Diagnostics for Antibiotic Resistant Infections R. Shawar, None.


K. Shea: None. A. Hobbs: None. T. Jaso: None. J. Bissett: None. E.

Douglass: None.



(ICHS)) S. A. Shelburne, None.


Convention B. Shen, None.

Antiretrovirals for Prevention and Treatment A. Shibata, None.

Emerging Viral Challenges S. Shresta, None.


to Treating Bacterial Infections H. A. Shuman, Melinta Therapeutics Consultant.


N. Siddique: None. M.A. Abbas: None. S. Rafique: None. R. Farooq:

None. K. Naeem: None.

Global Health and Emerging Infections T.R. Siddiqui: None. S. Ghazal: None. S. Bibi: None. W. Ahmed: None.

HIV Cohorts Studies M. J. Silverberg, None.

AST Update: Clinical and Laboratory Impact P. Simner, None.


the International Society of Anti-Infective Pharmacology (ISAP)) R. Singh, Past employee of AstraZeneca Pharmaceuticals Inc.

Models and Technologies for Studying Pathogenesis E. P. Skaar, None.




M. A. Slavin, Merck Grant Investigator. Pfizer Grant Investigator. Astellas

Grant Investigator. Gilead Sciences Grant Investigator. Merck Scientific

Advisor (Review Panel or Advisory Committee). Gilead Sciences cientific



Listed by Session


M. A. Slavin, Merck Grant Investigator. Pfizer Grant Investigator. Astellas

Grant Investigator. Gilead Sciences Grant Investigator. Merck Scientific

Advisor (Review Panel or Advisory Committee). Gilead Sciences cientific


The Science of Learning M. Smith, None.


M.S. Smith: Employee; Viracor-IBT Laboratories. J. Nutt: Employee;

Viracor-IBT Laboratories. B. Schindel: Employee; Viracor-IBT Laboratories.

M. Altrich: Employee; Viracor-IBT Laboratories.

Challenges of Infections in Lung Transplantation L. Snyder, None.

Primer on Transplantation M. So, Merck, Pfizer Consultant.

Bacterial Communication V. Sperandio, None.

Zika Virus: An Emerging Threat

K. St. George, ThermoFisher, Collaborator. Douglas Scientific, Collaborator.

ThermoFisher, Research Relationship.


K. St. George, ThermoFisher, Collaborator. Douglas Scientific, Collaborator.

ThermoFisher, Research Relationship.

Epidemiology and Control of Nosocomial MDRO A. J. Stewardson, None.

Epidemiological Methods to Evaluate the Added Burden of MDRO

Infection A. J. Stewardson, None.

Myths in Infection Control A. J. Stewardson, None.


G. A. Storch, GenMark, Abbott, FebriDx Consultant. BioFire Grant

Investigator.

RNA Modulation and Cellular Signals in Antimicrobial Resistance C. Suelter: Investigator; STRECK. N.D. Hanson: Grant Investigator; STRECK.

Course in Medical Mycology D. A. Sutton, None.


A. Takahashi-Nakazato: None. N. Goto: None. K. Tsuchiya: None. H.

Gatanaga: None. S. Oka: None.



Anti-Infective Pharmacology (ISAP))

V. H. Tam, The Medicines Company Grant Investigator. Tetraphase,

Theravance Scientific Advisor (Review Panel or Advisory Committee).

Tricky Choices Regarding Appropriate Antimicrobial Prescribing P. Tamma, None.


S.H. Tan: None. W.S. Pang: None. Q.Y. Quek: None. K.L. Chan: None.

L.C. Eng: None. L.S.Y. Ng: None. T.Y. Tan: None.

The Science of Learning K. Tanner, None.


E. Tartari: None. F. Bellissimo-Rodrigues: None. D. Pires: None. M.

De Kraker: None. C. Kilpatrick: None. B. Allegranzi: None. D. Pittet:

None.

New Antifungals

A.M. Tatara: None. A.J. Salter: None. P.D. Kontoyiannis: None. E.

Watson: None. N.D. Albert: None. G.R. Bennett: None. A.G. Mikos:

None.

Clinical Mycology

A.M. Tatara: None. A.J. Salter: None. P.D. Kontoyiannis: None. E.

Watson: None. N.D. Albert: None. G.R. Bennett: None. A.G. Mikos:

None.



(ICHS)) Y. Taur, None.

Biosafety and Biosecurity Lessons to Be Learned J. Taylor, None.


J.L. Taylor: None. D. Balawender: None. M. Neudeck: None. L.E. Parrish-

Thompson: None. K. Zamborsky: None.

Novel Strategies to Help Antibiotics to Play their Role L. M. Teixeira, None.

The Human Microbiome as a Reservoir of Antimicrobial Resistance Genes L. M. Teixeira, None.


in Gram-positive Bacteria L. M. Teixeira, None.


Listed by Session


Continuous and Emerging Challenges, Mechanisms and Epidemiology L. M. Teixeira, None.


(PK/PD)

A.K. Thabit: None. M.L. Monogue: None. D.P. Nicolau: A. Board

Member; Tetraphase Pharmaceuticals, Inc.. Grant Investigator; Tetraphase

Pharmaceuticals, Inc..

Making an Impact: Utilization and Outcomes in the Microbiology Lab E. S. Theel, None.



Anti-Infective Pharmacology (ISAP)) U. Theuretzbacher, None.

Models and Technologies for Studying Pathogenesis W. E. Thomas, None.

Carbapenemases

G.K. Thomson: None. J.W. Snyder: None. Y. Doi: None. K.S. Thomson:

Consultant; BD Diagnostics.


Communication J. Thorp, None.

New insights on Emerging Resistance Mechanisms in Gram-negatives E. Thulin: None. M. Knopp: None. D.I. Andersson: None.

More Trouble from Ticks in 2016 R. Tokarz, None.


Cooperation with the Pediatric Infectious Diseases Society (PIDS)) K. A. Top, None.

Difficult Viral Infections in HSCT

H. A. Torres, Gilead Sciences, Merck & Co., Inc., and Vertex Pharmaceuticals

Grant Investigator. Gilead Sciences, Janssen Pharmaceuticals, Inc., Merck &

Co., Inc., Vertex Pharmaceuticals, Novartis, Genentech, Astellas, Pfizer, and

Theravance, Inc. Scientific Advisor (Review Panel or Advisory Committee).


PulseNet A. Tran, None.



T.T. Tran: None. C. Garcia de la Maria: None. N. Mishra: Grant

Investigator; Merck. J. Miro: None. M. Rybak: speaker or have

supported research from Allergan, Bayer, Cempra, Merck, Sunovian, The

Medicine Company and is partially supported by NIAID R01AI12400-01 and

R21 AI109266-01. P. Sullam: None. A. Bayer: Research grants from: NIH-

NIAID; ContraFect Corp; Theravance Pharmaceuticals. C. Arias: Consultant;

Theravance, Cubist, Bayer. Grant Investigator; Theravance. F. Investigator;

Forest. Scientific Advisor (Review Panel or Advisory Committee); Cubist,

Bayer.Speaker's Bureau; Forest, Theravance, Pfizer, Astra-Zeneca, the

Medicines Company, Cubist, Novartis.


PulseNet E. K. Trees, None.

Ethics in Laboratory Medicine I. Trehan, None.


R. Tsivkovski: Employee; The Medicines Company. M. Totrov: Employee;

Molsoft. O. Lomovskaya: Employee; The Medicines Company.

Antimicrobial Stewardship I P.M. Tulkens: None.

DIY Microbiomes and Metabolomes

P. Turnbaugh, Seres Therapeutics Board Member. Pfizer Consultant.

MedImmune Grant Investigator.

Clinical Mycology

T. Ueda: None. Y. Takesue: None. K. Nakjima: None. K. Ichiki:

None. A. Doita: None. Y. Wada: None. T. Tsuchida: None. Y.

Takahashi: None. M. Ishihara: None. T. Kimura: None.

Carbapenemases

S.B. Vakulenko: None. C. Smith: None. Z. Nossoni: None. M. Toth:

None. N. Stewart: None.


Listed by Session


N.Q. Nguyen: None. K.M. Papp-Wallace: Grant Investigator; Wockhardt,

Merck, AstraZeneca, Actavis. R.A. Bonomo: Grant Investigator; Wockhardt,

Merck, AstraZeneca, Actavis, GSK. F. van den Akker: Grant Investigator;

Wockhardt.

The Human Microbiome as a Reservoir of Antimicrobial Resistance Genes W. van Schaik, None.


the Genomic Era D. Van Tyne, None.

Zika Virus: An Emerging Threat P. F. C. Vasconcelos, None.

Emerging Viral Challenges P. F. C. Vasconcelos, None.


Clinical Laboratory S. Vasoo, None.


A. Venkatasubramaniam: None. T. Kort: None. N. Williston: None. S.

Patel: None. G. Liao: None. R. Campos: None. R. Adhikari: None. S.

Krishnan: None. J. Aman: None.


Pathologie Infectieuse de Langue Française (SPILF)) A. Venkatesan, Medimmune, Inc. Board Member.


Qualitative Research for Dummies J. Verran, None.


Continuous and Emerging Challenges, Mechanisms and Epidemiology B. Vester, None.

Parasitology and Anti-parasitic Agents F. Vicente: None. F. Annang: None.

President's Forum - Viruses: Vital Members of Polymicrobial

Communities H. Virgin IV, PierianDx Founder.


Strategies

M. Barbier: None. A. Menetrey: None. A. Haouala: None. J. Bravo:

None. F. Wittke: None. C. Jacqueline: None. G. Vuagniaux: None.

New insights into Urinary Tract Infections

F. Wagenlehner, MSD, Bionorica, AstraZeneca, Marpinion, Janssen, Astellas,

GSK, Achaogen Consultant. MSD, Bionorica, AstraZeneca, Astellas,

Achaogen Investigator.

Aspergillosis following Viral Infections A. Waghmare, Gilead; Ansun Research Contractor.

Advances in Clinical Microbiology from the Horse's Mouth

J. Wain, Discuva Ltd. Board Member. Bactevo Ltd Board Member.

Hoffman La-Roche Collaborator. Hereaus Ltd., Collaborator. Hoffman La-

Roche Scientific Advisor (Review Panel or Advisory Committee).

Nosocomial Outbreaks M. S. Walters, None.


K. Wang: None. W. Chou: None. C. Chang: None. W. Chang: None. S.

Fang: None.

AST Update: Clinical and Laboratory Impact H. Wang, None.

Early New Antimicrobial Agents P. Warn, Spero Therapeutics Research Contractor.


& Adolescent

A. Warris, Pfizer, Gilead Consultant. Gilead Research Relationship. Basilea



Microbiology Educator (Supported jointly by IDSA and AMSMIC)

R. Watkins, Certum Informatics, Atlanta GA Board Member. Certum

Informatics, Atlanta GA, Shareholder (excluding diversitied mutual funds).

Update on Chikungunya Epidemiology, Treatment and Vaccination


Medicine and Hygiene (ASTMH)) S. Weaver, None.

Emerging Viral Challenges S. Weaver, None.


in Clinical and Public Health Microbiology

D. Weibel, Agri Diagnostics Inc. Board Member. BluDiagnostics Inc.

Board Member. Amazon.com, Inc. Consultant.



Gynecology (IDSOG)) J. Weitkamp, None.


Listed by Session


Susceptibility Testing L. Westblade, None.


Society of Infectious Diseases Pharmacists (SIDP)) T. C. White, None.

Bacterial Communication M. Whiteley, None.

Models and Technologies for Studying Pathogenesis M. Whiteley, None.


the Undergraduate Curriculum C. A. White-Ziegler, None.


Microbiology Educator (Supported jointly by IDSA and AMSMIC) W. Wiechmann, None.


Stand in 2016?

M. Wilcox, Actelion, Alere, Astellas, AstraZeneca, Basilea, Bayer, Cubist,

Durata, European Tissue Symposium, J&J, Merck, Nabriva, Novacta, Optimer,

Pfizer, Sanofi Pasteur, Seres Consultant. Abbott, Actelion, Alere, Astellas,

Biomerieux, Cerexa, Cubist, Da Volterra, European Tissue Symposium, Merck,

Sanofi Pasteur, Summit, The Medicine Co, Qiagen Research Relationship.

Pfizer Speaker's Bureau.

Control of C. difficile Infection S. Wiles, None.

At the Intersection of Art and Microbiology S. Wiles, None.

Biosafety and Biosecurity Lessons to Be Learned D. E. Wilson, None.


Pathologie Infectieuse de Langue Française (SPILF)) M. Wilson, None.

Broadly Neutralizing Antibodies I. A. Wilson, None.


C. R. Wolfe, Theravance Consultant. Astellas Consultant. Merck Grant

Investigator. Ansun Biopharma Investigator. Gilead Research Contractor.

GSK Scientific Advisor (Review Panel or Advisory Committee). Cellerant

Therapuetics Scientific Advisor (Review Panel or Advisory Committee).

Janssen Pharmaceuticals Scientific Advisor (Review Panel or Advisory

Committee).

Clinical Applications of Next Generation Sequencing A. Wolfe, Astellas Scientific and Medical Affairs , Grant Investigator.

New insights into Urinary Tract Infections A. Wolfe, Astellas Scientific and Medical Affairs , Grant Investigator.

The Human Microbiome as a Reservoir of Antimicrobial Resistance Genes P. F. G. Wolffs, None.

New insights on Emerging Resistance Mechanisms in Gram-negatives D. Wolloscheck: None. J. Nguyen: None. H.I. Zgurskaya: None.


PulseNet A. Woron, None.

Bacterial Communication

G. Wright, Achaogen Research Contractor. Symbal Therapeutics Scientific

Advisor (Review Panel or Advisory Committee). Tetraphase Shareholder

(excluding diversitied mutual funds).

Future Microbiology-Predicting the Field in 2026 S. Yang, None.



(ICHS)) V. B. Young, Merck, Vedanta Consultant. MedImmune Grant Investigator.




Medicine and Hygiene (ASTMH)) A. Zaidi, None.


S. Zainal: None. L. Phee: None. H. Abdul Momin: None. D. Wareham:

None.


& Adolescent T. Zaoutis, None.


Listed by Session


E. Zasowski: None. T. Trinh: None. K. Claeys: None. M. Rybak:

Consultant; Allergan, Bayer, Cempra, Merck, Sunovian, The Medicines

Company, Theravance. Grant Investigator; Allergan, Bayer, Cempra, Merck,

Sunovian, The Medicines Company, Theravance, NIAID.Speaker's Bureau;

Allergan, Bayer, Cempra, Merck, Sunovian, The Medicines Company,

Theravance. A. Casapao: Speaker's Bureau; Theravance.


(PK/PD)

D. Zaytseva-Zotova: None. A. Zinchenko: None. T. Levada: None. D.

Andreev: None. Y. Shilov: None. E. Safarova: None. A. Horhota: None.

G. Troiano: None. S. Zale: None.



(ISAP)) M. Zeitlinger, None.

NIAID Training (T), Career (K), and Fellowship (F) Opportunities A. Zeituni, None.

Chemistry and Microbiology BFF: Beyond MALDI-TOF MS Technology A. M. Zelazny, None.

Update on the Laboratory Diagnosis of Urinary Tract Infections T. Zembower, None.

Course in Medical Mycology S. Zhang, IBIS/Abbott Molecular Research Contractor.

Chemistry and Microbiology BFF: Beyond MALDI-TOF MS Technology Z. Zhao, None.

Antimicrobial Stewardship I Z. Zhiyong: None. J. Li: None.

RNA Modulation and Cellular Signals in Antimicrobial Resistance X. Zhou: None.


Progress Reports W. Zingg, None.

Microbe 2016 Disclosures Listed by Session

Documents

Transcript of Microbe 2016 Disclosures Listed by Session